Reprogramming strategies for cord blood cd34+ cells with different mitochondria phenotype by Monteiro, João Luís Cardoso Dias
1 
 
 
 
Faculdade de Ciências e Tecnologia da 
Universidade de Coimbra  
 
 
 
 
 
Reprogramming strategies for cord blood cd34+ 
cells with different mitochondria phenotype  
 
 
 
 
 
 
 
João Luís Cardoso Dias Monteiro 
Coimbra, Março 2013  
 
 
2 
 
 
Faculdade de Ciências e Tecnologia da 
Universidade de Coimbra  
 
     PTDC/SAU_ENB/113696/2009 
 
 
 
Reprogramming strategies for cord blood cd34+ 
cells with different mitochondria phenotype  
 
Thesis submitted for the degree of master in Biomedical Engineering  
Supervisors: Prof. Dr. Ricardo Neves (CNC) 
 
 
 
 
João Luís Cardoso Dias Monteiro 
Coimbra, Março 2013  
 
 
3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This copy of the thesis has been supplied on condition that anyone who consults it is 
understood to recognize that its copyright rests with its author and that no quotation from the 
thesis and no information derived from it may be published without proper acknowledgement. 
4 
 
Agradecimentos 
 A realização desta dissertação marca o final de uma importante etapa na minha 
vida. Deste modo gostaria de agradecer a todos que contribuíram de forma crucial 
para a sua concretização. 
 Em primeiro lugar agradeço aos meus pais, irmãos e amigos por todo o apoio, 
incentivo e paciência que demonstraram ao longo de todo o meu percurso académico. 
 Em seguida agradeço ao meu orientador, Professor Doutor Ricardo Neves, pela 
sua disponibilidade, espírito crítico e paciência que foram determinantes para o 
sucesso deste trabalho. 
 Gostava ainda de agradecer de forma especial à Ana Lima por toda a amizade, 
paciência e suporte demonstrados e que foram sem dúvida cruciais para a realização 
do trabalho laboratorial.  
Por fim agradeço a toda a equipa do Professor Doutor Lino Ferreira pela 
amabilidade, troca de conhecimentos e espírito de grupo demonstrados ao longo do 
meu estágio.   
5 
 
Abstract 
Induced pluripotent stem cells are an important alternative to avoid the use of 
embryonic stem cells. By controlling the epigenetic remodelling of a somatic cell it is 
possible to re-establish an embryonic like phenotype. Therefore this iPSCs (induced 
pluripotent stem cells) technology can be a great step in the regenerative medicine 
filed and drug toxicity screen.  However the limited efficiency of generation of iPSCs 
and some differences from ESCs (embryonic stem cells) phenotype and function are 
major obstacles to further advance in this area.  
As reprogramming depends on several stochastic events a good strategy could 
be the selection of an immature cell population, like the CD34+ derived from cord-
blood, since these cells are closer to pluripotency than fully differentiated cells. For 
selection of different sub-populations within the CD34+-cells traditional sorting 
techniques require the combination of several antibodies, which is a time consuming 
technique and requires skilled competences. In order to overcome these constrains we 
explored a new method to select a primitive population of CD34+ cord blood cells 
based on the uptake of the mitochondrial probe TMRM (Tetramethylrhodamine, 
methyl ester). We compared the reprogramming efficiencies of TMRM high and TMRM 
low populations after infection with a lentivirus vector that contained the 4 Yamanaka 
factors. Furthermore the oxygen environment during reprogramming was modulated 
using hypoxia and antimycin A. 
We were able to conclude that low TMRM uptake CD34+ cord blood cell 
population achieved better efficiencies in normoxia with higher expression of the main 
pluripotent genes (Oct4, Sox2 and Nanog). Both populations were characterized 
phenotypically and we were able to validate our sorting method to select immature 
cells.  
Both populations after reprogramming in hypoxia show a similar behaviour in 
terms of reprogramming. Nonetheless the low TMRM population had still higher 
expression levels of the main pluripotent genes. The antimycin A treatment combined 
with hypoxia allowed us not only to obtain similar reprogramming efficiencies in both 
populations but also to level the expression of Oct4, Sox2 and Nanog. 
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In conclusion we were able to create a new method to select the cells from the 
CD34+ cord blood population suitable for reprogramming studies reducing the use of 
antibodies and the time expended. This will not only reduce the complexity of the 
method but also will allow a reduction of the levels of stress imposed to the cells and a 
much more efficient cell sorting procedure. Furthermore there is still space for future 
improvements using modulatory agents as hypoxia and antimycin A. 
We hope that our work may contribute to the selection of an ideal cell 
population for reprogramming and therefore act as a booster of the reprogramming 
process. 
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Resumo 
Células pluripotentes induzidas são uma alternativa importante de forma a 
evitar o uso de células embrionárias. Ao controlar a remodelação epigenética de uma 
célula somatica é possível reestabelecer o fenótipo embrionário. Deste modo esta 
tecnologia (iPSC – induced pluripotent stem cell) poderá ser um grande passo no 
campo da medicina regenerativa e em monitorização de testes de toxicidade. No 
entanto a eficiência limitada na geração de iPSC e algumas diferenças em relação ao 
fenótipo e função comparado com as células estaminais embrionárias (ESCs – 
embryonic stem cells) são grandes obstáculos aos avanços nesta área.  
Como a reprogramação cellular depende de vários eventos estocásticos, uma 
boa estratégia seria a seleção de uma população imatura, como as CD34+ derivadas a 
partir do sangue do cordão umbilical, uma vez que estas células estão mais próximas 
da pluripotência do que células diferenciadas. Para seleção de diferentes sub-
populações dentro das CD34+ as técnicas tradicionais de sorting requerem a 
combinação de vários anticorpos, são demoradas e requerem técnicos competentes. 
De forma a ultrapassar estes problemas exploramos um novo método para selecionar 
uma população primitiva das células CD34+ do sangue do cordão umbilical baseado na 
captação de uma sonda mitocondrial TMRM (Tetramethylrhodamine, methyl ester). 
Nós comparamos as eficiências de reprogramação das populações com elevada e baixa 
captação de TMRM depois de infeção com um vector lentiviral que continha os 4 
factores do Yamanaka. Adicionalmente os níveis de oxigénio durante a reprogramação 
foram modulados usando hipoxia e antimicina A.  
Fomos capazes de concluir que a população CD34+ do sangue do cordão 
umbilical com menor captação do TMRM foi capaz de conseguir atingir melhores 
eficiências em normoxia e com maior expressão dos genes pluripotentes principais 
(Oct4, Sox2 e Nanog). Ambas as populações foram caracterizadas fenotipicamente 
permitindo-nos validar o nosso método de sorting para selecionar células imaturas. 
Após a reprogramação em hipoxia ambas as populações demonstraram um 
comportamento similar. No entanto a população com menor captação do TMRM tinha 
níveis mais elevados de expressão dos genes pluripotentes principais. O tratamento 
com antimicina A combinado com a hipoxia permitiu-nos não só obter eficiências de 
reprogramação semelhantes em ambas as populações como também equalizar os 
níveis de expressão de Oct4, Sox2 e Nanog. 
Em conclusão, fomos capazes de criar um novo método para selecionar as 
células CD34+ do sangue do cordão umbilical mais adequadas para estudos de 
reprogramação reduzindo o número de anticorpos e tempo gasto. Desta forma não só 
reduzir-se-á a complexidade do método como também permitirá uma redução dos 
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níveis de stress impostos às células e um procedimento de sorting mais eficiente. 
Adicionalmente existe ainda espaço para melhoramentos futuros usando agentes 
moduladores como a hipoxia e a antimicina A. 
Esperamos que o nosso trabalho venha a contribuir para a seleção de uma 
população celular ideal para reprogramação e desta forma reforçar o processo de 
reprogramação. 
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Introduction 
In modern society there is a great need to find new treatments for several 
disorders related with cellular dysfunction that highly compromise our quality of life 
and affect large groups of people. 
However the ability to restore cellular function is limited and often the 
replacement of organs and tissues through transplants is needed. Cell therapies like 
bone marrow transplants have already become a standard procedure in patients with 
blood-related disorders but the procedures depend on availability of compatible 
donors. Therefore the success of these strategies is dependent on immune tolerance, 
is limited by the number of cells that can be harvested and has a narrow range of 
clinical applications.  
It is in this context that pluripotent stem cells emerge as a new alternative. By 
allowing the replacement of damaged tissues they open new perspectives in medicine. 
These cells hold the capacity to differentiate in all types of cells present in the human 
body with the exception of the umbilical cord and placenta having therefore in theory 
an unlimited potential to generate any organ or tissue compromised by age, disease or 
injury. The most promising applications are in the treatment of cardiovascular 
diseases, diabetes, spinal cord injury, and degenerative and congenital diseases.1 
There are currently two main sources for the collection of stem cells: the 
embryonic stem cells and the adult stem cells. Embryonic stem cells can be obtained 
from the inner cell mass of the blastocyst; this requires the destruction of an early 
embryo generating much ethical debate around it 2-4. To overcome these problems 
scientists were forced to find other stem cell sources for regenerative medicine. 
Human cord blood is an attractive solution as a source of adult stem cells because of 
the great advantage of the establishment of blood banks that can store the cells for 
future transplants. Besides, there is also the fact that it constitutes a young tissue 
collected after birth being less likely to contain mutations accumulated by age, 
radiation and viral infections. 
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 A target sub population within these cells is the CD34+ fraction of the cord 
blood that is composed of hematopoietic stem and progenitor cells. It is thought that 
these cells have suffered fewer cell cycles and are in a more primitive state (less 
differentiated) than the remaining cord blood.5 The peripheral blood is another source 
of CD34+ cells but with a reported efficiency 10 times lower on isolation6 and with a 
lower proliferative state caused by lower telomerase activity7. 
 Still, a critical problem for cord blood use in cellular therapy resides in the 
limited number of cells that can be collected from a single donor. Transplants of 
hematopoietic cells (multipotent) can be performed but require a high number of cells 
to restore regular function. The use of cells derived from cord blood in transplants 
would obligate the combination of cells gathered from different donors which could 
result in a high probability of immune rejection.8 Other disadvantage resides in the 
small range of applications because of the limited capacity of these cells to generate 
other lineages, since they are only multipotent.  
In an attempt to overcome the technical limitations and ethical issues raised 
against the current pluripotent and multipotent cell sources, science is evolving in the 
direction of reprogramming somatic or multipotent cells back to pluripotency – the 
induced pluripotent stem cells (IPSc).  
Nonetheless there are still many barriers to surpass for the clinical translation 
of IPS-derived cells as therapeutic agents. Some of the obstacles are related with 
identifying the best source of cells for reprogramming; improving the efficiency of the 
method; controlling the maintenance of the self-renewal capability and guiding the 
differentiation process towards a specific cell type.  
One of the main purposes of this work is to find which types of cells within the 
CD34+ population are more effectively reprogrammable. The glycolytic metabolism of 
the CD34+ is another attractive feature for reprogramming strategy. As most 
differentiated cells rely on oxidative phosphorylation they require a metabolic shift 
when the cells are reprogrammed 9 . We believe that in the cord-blood CD34+ 
population there are sub-populations that can be distinguished by their characteristics 
in terms of mitochondrial membrane potential. This will distinguish cells by differences 
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in the metabolic state and production of reactive oxygen species, which is determinant 
for the cell fate. 
In order to address some of the main strategies of reprogramming and the main 
obstacles faced during this process the next pages of this introductory summary focus 
on basic concepts of stem cell biology. 
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1.1 Stem cells 
Stem Cell Types 
 
There are essentially two stem cell types that can be harvested from human 
donors: embryonic stem cells (ESC) and the adult stem cells. The ESC have high self-
renewal ability and are pluripotent, which means they are capable to originate the 
three germ layer tissues: endoderm, mesoderm and ectoderm. On the other hand, the 
adult stem cells have a more restricted self-renewal capability and are only 
multipotent. 
 
Figure 1 – Stem cells sources (adapted from http://www.sabiosciences.com/pathwaymagazine/pathways9/biology-great-promise-
stem-cells.php) 
 
Stem cells reside in highly regulated microenvironments, called niches, which 
maintain a constant dialogue between the cells and their surroundings and keeps a 
balance of self-renewal and differentiation. Niches have the ability to shield the cells 
from apoptosis stimulus, differentiation and over proliferation; which if it is not 
properly controlled may lead to cancer.  
Stem cells can have a quiescent behavior or can undergo symmetric and 
asymmetric division.  Within asymmetric division the mother cell gives rise to two 
different daughter cells, one that keeps the stem cell identity and other one that 
acquires a differentiated phenotype. On the other hand symmetric division leads to 
the generation of two identical daughter cells, either with a stem cell phenotype or 
differentiated phenotype. These different fates can be due to different 
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microenvironments or due to the effect of intrinsic factors that are differently 
segregated. 
  
Embryonic Stem cells 
In 1998 the first isolation of human embryonic stem cells from in vitro 
fertilization embryos was reported2. 
Embryonic stem (ES) cells are pluripotent cells (capable of originating the three germ 
layers: ectoderm, mesoderm and endoderm) derived from the inner cell mass (ICM) of 
Blastocysts (which are formed around day 5 to 6 of embryonic development), and that 
have great potential for differentiation.  
These cells can be characterized by their unlimited proliferation in vitro (while 
preserving a normal diploid karyotype); capacity to form a teratoma (a tissue 
composed by the three germ layers) after injection subcutaneously into an immune 
deficient animal; and ability to originate chimeras (a single organism with two or more 
populations of genetically distinct cells) after fusion with an early embryo or a fertilized 
egg. 
Characterization of these cells can be made by confirming the presence of 
specific markers or proteins (as shown in table 1). 
 
 
Table 1- Comparison of cell markers and culture conditions in human and mouse embryonic stem cells. *Glycolipids. **Keratan 
chondroitin sulphate proteoglycans. ***Tetraspannin transmembrane proteins. AP, alkaline phosphatase; EB, embryoidbody; ESC, 
embryonic stem cell; FGF4, fibroblast growth factor-4; LIF, leukaemia inhibitory factor; OCT4, octamer-binding transcription factor-
4; SOX2, SRY-related high-mobility group (HMG)-box protein-2; SSEA, stage-specific embryonic antigen; TRA, tumour-rejection 
antigen10  
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Although embryonic stem cells have desirable features for cell therapy their use 
in allograft transplants is associated with immune responses in the host. These cells 
increase their immunogenicity by gaining human leukocyte antigens during 
differentiation, which might increase the risk of rejection. Other problem resides on 
the lack of proper imprinting patterns and regulation of certain genes which might lead 
to spontaneous and uncontrolled differentiation resulting in developmental 
abnormalities11. 
On the other hand working with human embryos raises ethical issues that are 
still on debate. The collection of the cells implies the destruction of human embryos, 
which goes against many beliefs and values in our society. The commercial value over 
these cells and legitimacy of patents are other questions that need to be answered.4 
As pluripotency and self-renewal are the most relevant characteristics of the 
embryonic stem cells, this chapter will now focus on a small review on the main agents 
that regulate these pathways. 
Transcription factors 
 
 Transcription factors are proteins capable of recognizing specific DNA 
sequences and can either activate or prevent transcription. Like most proteins they are 
transcribed in the nucleus and translated in the cytoplasm. Their return to the nucleus 
where they can interact with DNA is assured by a nuclear localization signal. This signal 
consists in positively charged sequences of lysine or arginine residues that target 
proteins and allow them to bind to a importin. The complex can then move through 
the nuclear pore. Within the nucleus, the transcription factor is released and is now 
free to interact with the enhancers and promoters of the genes. 
 
 
Figure 2 - On active genes, enhancers are bound by multiple transcription factors, which recruit cofactors that can linteract with 
RNA polymerase II. RNA polymerase II generates a short transcript and pauses until pause-release factors and elongation factors 
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allow further transcription. Chromatin regulators, like histone-modifying enzymes such as TrxG, Dot1, and Set2, are recruited by 
transcription factors or the transcription apparatus and mobilize or modify local nucleosomes.12 
 
The enhancers are cis-acting DNA sequences that can greatly increase gene 
expression. They can be located upstream or downstream of the gene and act by 
allowing modifications on the DNA conformation in the presence of transcription 
factors. These changes will result in a better interaction between the RNA polymerase 
II and the promoters.  
This interaction with the enhancer may result in multiple mechanisms to 
regulate genetic expression:  
 Stabilization or blocking of RNA polymerase binding;  
 Recruit co-activators or co-repressors of the transcription factor DNA complex 
 Catalyse histone acetylation by promoting the activity of histone 
acetyltransferase (HAT) which weakens the association of the DNA with the 
histone, making the DNA more accessible promoting the activity of the 
transcription machinery; 
 Catalyse the histone de-acetylation by the histone dacetylase (HDAC) activity, 
which participates in the opposite reaction of HAT. 
 
Figure 3- Acetylation reaction mediated by HAT, where acetyl coenzyme A is the donor of the acetyl group (COCH3). And opposite 
reaction mediated by HDAC13  
 
Another important group of enzymes that are responsible for histone 
modifications are the: histone methyltransferases (HMTs) and histone demethylases. 
HMTs are usually related with gene activation/silencing by transferring a methyl group 
(CH3) to a specific lysine or arginine on histone 3 and 4. On the other hand, histone 
demethylases activate/silence gene expression by removing the methyl group. 
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Key transcription factors in pluripotency - Oct4, Sox2 and Nanog 
 
Oct4 (also known POU5F1) is considered a key regulator of pluripotency. For 
this reason it is often used as a reprogramming factor and its expression is an evidence 
of pluripotency. Its expression starts right from the 2 cell stage especially prior to 8 cell 
stage until the blastocyst stage where it is strongly expressed in the inner cell mass 
(ICM). As differentiation occurs, the levels of this protein decrease being almost absent 
in most somatic cells.  The activation of this gene is vital for embryogenesis since 
embryos with Oct4 knockout, fail in the development of ICM and die after blastocyst 
stage4, 14. Additionally, this factor has been reported as crucial to promote survival of 
germ line cells as disruption of its expression leads to apoptosis15. 
Oct4 can bind the downstream promoters (AGTCAAAT) activating or suppressing 
the expression of several genes. Among the targeted genes regulated by this protein 
are important mitochondria enzymes like the pyruvate carboxylase (Pcx) and ATP 
synthase (Atp5d). The products of these genes are considered to be responsible for the 
decision of the metabolic behaviour of the cell.16, 17 
 Down-regulation of genes may also occur by the formation of heterodimers with 
other factors like Sox2 (SRY (sex determining region Y)-box 2). This is another 
important transcription factor that is also expressed in the ICM and in precursor cells 
of the nervous system. By combining with Oct4 controls the expression of genes such 
as Fgf4, UtF1, NANOG, Fbx15 and Oct4 itself. 
 
The third main pluripotent gene is Nanog. The important role of Nanog relies on 
the maintenance of self-renewal and undifferentiated state by modulation of the 
transcription factors Oct4 and Sox2. Other targets of this factor consist in: 
 Foxd3, a transcriptional repressor important for the maintenance of the 
inner cell mass; 
 Setdb1 gene which encodes an enzyme that methylates histone H3 on 
lysine 9 (H3K9) and is crucial for repression of a subset of genes encoding 
developmental regulators in ES cells18.  
 Rif1 activation which associates with dysfunctional telomerases and has a 
role in the S-phase checkpoint in the response to DNA damage 
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An interesting feature of these three transcription factors resides in their auto 
regulatory loop by targeting the promoters of their own genes as shown in 
figure 3. This mechanism is believed to promote stability of gene expression 
and reduce response time to an external stimulus. 
 
 
 
Figure 4- Selected Components of ESC Core Regulatory Circuitry and Its Disruption during Differentiation. The genes are dark 
blue rectangles; the gene products are yellow circles, the hexagons are miRNA promoters.  Lin28 inhibits the maturation of the 
Let-7g miRNAs wich are required for differentiation. Oct4, Sox2, and Nanog are also associated with SetDB1- and PcG-repressed 
protein-coding and miRNA genes that are poised for differentiation12.  
 
The interruption of this auto regulatory cycle results in down-regulation of the 
main transcription factors and the loss of the pluripotent state as shown in figure 5. 
 
Figure 5 - The loss of pluripotent state during differentiation involves the silencing of the Pou5f1 gene, the proteolytic 
destruction of Nanog by caspase-3, and miRNA-mediated reduction in Oct4, Nanog, and Sox2 mRNA levels12  
Other transcription factors – Lin28, Klf4, c-Myc 
Although not so important as the pluripotent genes mentioned above, other 
transcription factors have an important role in the maintenance of several features of 
pluripotent cells. 
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c-Myc is an important transcription factor that is involved in the regulation of 
transcription of about 10% of the genome19. c-Myc is also a component of active 
chromatin by associating with various histone acetyl-transferase complexes (HAT), 
such as p300 and TRRAP, and thus having an important role in opening chromatin 
conformation through histone acetylation and favour the access of Oct4 and Sox2 to 
their targets. Another important effect of c-Myc is the inhibition of p21 promoter an 
important regulator of DNA repair, preventing its activation by p53. The result is an 
increase in proliferation since cell cycle will not be interrupted at the G1-S 
checkpoint20. On the other hand, a sustained expression of c-Myc will increase the 
apoptosis in a p53 mediated way14. This gene is believed to promote mitochondria 
biogenesis21.  
Klf4 importance resides in the control of proliferation and apoptosis. It has 
been reported that this transcription factor has an important effect in balancing the 
action of c-Myc. At the same time that counters the apoptotic effects of c-Myc by 
repressing p53 it also inhibits proliferation by activating p2114, 22.  
Lin28 protein is localized both in the nucleus and cytoplasm and its role in 
pluripotency is essentially related with inhibition of let-7 family miRNAs by diminishing 
their maturation. The lin28/let-7 axis is an important regulator of cell proliferation, 
since let-7 miRNAs are responsible for blocking the expression of pro mitogenic factors 
such as c-Myc and Ras. For this reason lin 28 can replace the use of c-Myc in 
reprogramming studies23. Lin28 also interacts with mRNAs of genes involved in cell 
cycle progression such as cdk4, cyclins A and B and contributes for the maintenance of 
the pluripotent state24. Additional functions are related with the stabilization of the 
transcription of mRNA from genes in the pluripotent transcriptional network and 
expression of the Oct 4 gene at post transcriptional level25. 
Adult stem cells 
 
Although ESCs seem to be the perfect candidates for clinical trials and 
platforms for studies of new drugs or pathways their use as been controversial 
because of ethical concerns. For this reason the use of adult stem cells became a very 
important matter of study. 
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Hematopoietic stem cells (HSCs) from bone marrow are responsible for the 
creation of all the blood cell types and are currently being used in transplants. 
Recently, other adult stem cells have been found in a variety of different tissues. These 
findings have generated a great deal of excitement for expanding the use of stem cells 
for treatment of diseases. The adult tissues that have been reported to contain stem 
cells include the brain, bone marrow, peripheral blood, blood vessels, skeletal muscle, 
skin, and liver3. In addition to these lineage-restricted adult stem cell types, 
mesenchymal stem cells are a less differentiated form of stem cell that have the ability 
to mature into a more diverse variety of cells.26 
 
There are however several obstacles restraining the uses of adult stem cells in 
research and clinical therapies namely the problem related with the procedure of 
isolation and culture of these cells. Although there can be several sources to obtain 
adult stem cells, there is a limit for them to maintain their self renewal capability for 
long periods in culture without expecting a significant differentiation. The same 
problem is observed in stem cells derived from umbilical cord blood.[5]  
Other issues concerning the use of adult stem cells can be27: 
 
 the possibility that the cells have accumulated mutations  caused by age or 
radiation;  
 the limited capacity of differentiation; 
 the risk of immune response after allogenic transplants; 
 the amount of cells that can be harvested and that can prove to be insufficient 
for the desired applications;  
 
Human Cord blood hematopoietic stem cells 
Human cord blood is an important accessible source to obtain hematopoietic stem 
cells. Preservation of these cells is currently being made for blood and autoimmune 
disorders as these cells contain some differentiation potential. Their ability to generate 
immune system cells, adipocytes 28, cardiomyocytes 29, endothelial cells 30, 
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fibroblasts31, liver cells 32, osteochondrocytes 33, and pancreatic cells 34 has been 
reported. 
Characterization of the hematopoietic population has been associated with 
expression of CD34+ marker35. However this is a very heterogeneous group with major 
differences in terms of clonogenic capacity, suggesting the existence of different 
populations with variable gene expression and metabolic status. 
The induction of pluripotency – reprogramming to iPSC (induced pluripotent stem 
cells) 
The limitations in the use of the different stem cell sources in cell therapy lead 
researchers to look for alternative ways to generate cells that could fulfil the need for 
high cell number and differentiation potential. This search reached its goal with the 
advent of the reprogramming technology. Reprogramming consists in the de-
differentiation of cells which have undergone some degree of differentiation. This re-
establishing of the pluripotent capacity will avoid ethical issues involving the use of 
embryos. Furthermore the problem with immune response will also be diminished 
because of the possibility of use of cells from the patient.  
As shown in the figure 6 this process consists in the introduction of reprogramming 
factors in a differentiated cell. The reprogramming factors which can be transcription 
factors or micro RNAs will induce activation of the regulatory loop of the main 
pluripotent genes. This will lead to the activation of the pluripotency cascade and the 
repression of the machinery responsible for cell differentiation (as shown above in 
figure 4). 
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Figure 6 – Schematic representation of the reprogramming process   (adapted from 
http://flipper.diff.org/app/pathways/info/4475 ) 
 
Reprogramming strategies 
The first attempts to generate induced pluripotent stem (IPS) cells were made by 
using nuclear transfer. This method consists in the fusion of a nucleus, removed from a 
somatic cell, with an egg cell which had its nucleus removed. Through this approach 
the somatic nucleus can be reprogrammed by the factors that are present in the egg 
cell. After stimulation by an electric shock the cell begins to divide by mitosis and 
originates cells with practical identical DNA of the donor of the somatic cell. The great 
promise of this technique was based on the capability of the oocyte to provide an ideal 
environment for reorganization of gene expression. As all the crucial intervenients 
would already be present in the correct proportion the number of stochastic events 
would surely decrease. 
This technique is however hard to be applied in mammals due to the small size of 
the eggs which would result in a low efficiency process. The main problem that 
restrains its use in humans is however the ethical concern about the possible creation 
of human clones if the cells were implanted in a uterus during the blastocyst stage. 
Furthermore there is also the risk of immunogenicity caused by the mitochondrial DNA 
inherited from the oocyte36, 37. 
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The problems mentioned above could not be ignored and forced science to find 
new alternatives to artificially create pluripotency. Since then several strategies have 
been explored in order to improve efficiency and safety while aiming to make it a 
standard practice in medical procedures. Figure 7 summarizes the main strategies used 
until now. 
 
Figure 7 – Main differences between reprogramming strategies. 36 
 We will now focus on an overall review about the first two parameters of the 
table as they represent the most critical points in this type of study. We will describe 
the relevant work in this area while addressing the main advantages and obstacles that 
have been developing in this still young technology. 
2.1 Choice of reprogramming factors 
Viral vectors were the first successful method for generation of IPS cells. Shinya 
Yamanaka in 2006 showed that is possible to generate induced pluripotent stem cells 
by artificially reprogramming Mouse Embryonic Fibroblasts (MEF). By using a retrovirus 
system Yamanaka’s group reversed the differentiation process in somatic cells and 
confirmed the presence of embryonic features. [4] They selected c-Myc, Oct4, Sox2 and 
Klf4 as the best reprogramming factors between several candidates because of the 
similar morphology and proliferative characteristics of the reprogrammed cells with ES 
cells. 
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Later Thomson et al (2007) demonstrated successful reprogramming of human 
foreskin fibroblasts with the transcription factors Sox2, Oct4, Lin28 and NANOG also 
based in a viral system (lentivirus). The c-Myc transcription factor, which enhances 
reprogramming efficiency by interacting with chromatin and allowing Sox2 and Oct4 to 
bind to their targets, was not used due to its induction of ES differentiation and 
apoptosis23, 38. 
Most of the work in this field uses a combination of these 2 sets of factors. Oct4 
and Sox2 are the most critical since they have proven in some cases to be sufficient to 
induce pluripotency39.  
 
2.2 Reprogramming Factor Delivery 
 
Viral systems as vectors to generate pluripotency 
The main goal of creating a viral vector for gene delivery is to achieve genomic 
expression with high efficiency. Viruses are excellent at doing this; although one 
should be careful to minimize the risk of mutations and the transfection of unwanted 
genes or the risk of creating competent viruses that represent a danger not only to the 
host, if the cells would be transplanted, but also for the operator. 
Retroviruses were the traditional method used for gene delivery. There were 
however several disadvantages in the use of these vectors: 
 Random insertion of genes within the genome, which can activate oncogenes; 
 Possible transgene reactivation upon cell differentiation; 
 Requirement of proliferating cells for infectivity; 
 Poor in vivo delivery and transfection resulting in low reprogramming 
efficiency40. 
 
Among retroviruses there is a group that deserves special attention, the 
lentivirus, which can enter the nuclear envelope and thus are capable of replicating in 
non-dividing cells, making the reprogramming process more efficient and faster. 
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Figure 8 – Schematic representation of a lentivirus. (adapted from 
http://www.vcu.edu/oehs/chemical/biosafe/lentiviralvectors.pdf) 
 
 
Table 2 – Function of lentiviral proteins. (adapted from http://www.vcu.edu/oehs/chemical/biosafe/lentiviralvectors.pdf) 
 
The infection starts with the binding of the viral surface protein to the receptor 
of the host cell. After this the capside of the virus disassembles by a product of the pol 
gene and the reverse transcription takes place forming a double stranded DNA. The 
double stranded DNA together with other viral proteins like MA, IN and VPR (Table 2) 
will form a preintegration complex (PIC), which has the ability to enter the nucleus of a 
non-dividing cell. MA and IN are recognized by importin α, this complex then binds to 
importin β to be transported to the nucleus. Accessory proteins like VPR act by 
increasing the affinity with importin α and/ or by acting as analogues of importin β. IN 
is responsible for the cleavage of the DNA at both ends allowing it to be integrated in 
the host genome without a preferential integration site41.  
27 
 
 Ribosomes of the host cell will then translate viral mRNA that codifies the 
proteins for the formation of a new virus. This step requires that the viral protease 
cleaves the viral proteins in smaller mature proteins which can form a new virus.  
 
Another interesting feature in the use of these vectors is the silencing of the 
transfected genes by DNA methylation as reprogramming proceeds14.  
 
Although the efficiency achieved with this method is reasonable when 
compared to the current alternatives there are still obstacles that need to be 
overcome. One of these is the problem of random DNA insertion of the transgenes. 
This could lead to changes in the transcription pattern of genes located in the genomic 
vicinity of the integration site. This effect is especially problematic if it occurs close to 
oncogenes or tumour suppressor genes giving origin to cancer.42 
 
Evolution of viral reprogramming vectors 
 
  The risk of generation of a competent virus (capable of replication) is also 
preventing clinical applications.43 To address this problem several changes have been 
made in the construction of the viral vectors. First generation vectors used three 
plasmids. One containing all the genes of the HIV-1 virus except the envelope protein 
and a CMV (Cytomegalovirus) promoter with the packaging sequence removed.44 A 
different plasmid was used for the envelope protein. And on an additional plasmid was 
the cDNA of the genes to be transfected, two long terminal repeats (LTR´s) containing 
regulatory elements for gene expression, elements for gene packaging and reverse 
transcription. Traditionally the packaging genes are separated in different plasmids for 
security measures. As all of these genes are necessary to generate a competent virus 
and the only promoter is in the plasmid carrying the protein coding genes it would be 
very difficult to generate a replication competent virus because it would be necessary 
to have as many recombinant events between the plasmids as the number of 
packaging plasmids. This would be very improbable but still possible. 
On the second generation all the accessory viral genes (vif, vpr, vpu and nef) 
were deleted from the packaging plasmid diminishing the number of HIV-1 genes 
present from the packaging vector and retaining only Tat and Rev.45 
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The third generation vectors were characterized by replacement of Tat 
promoter for other heterologous promoters and the delivery of Rev on an additional 
plasmid.46 
Additionally other important modification was the deletion of 3’U3 promoter. 
Lentiviruses have two promoters, one in the U3 region of the 3’ side and another in the 
U3 region of the 5’ side. During reverse transcriptase the promoter in the 5’ side is 
deleted. Reverse transcriptase uses the promoter in the 3’ for the creation of the 
double stranded DNA. By exploring this mechanism researches deleted the promoter 
in the 3’ region making impossible for the virus to create viral mRNA with packaging 
sequence. Another change introduced was the replacement of Tat by stronger 
promoters in the 5’ side of the cDNA.47 
 
Integration free techniques   
 
Since viral integration constitutes a major risk to the host, there are several 
approaches that try to overcome this problem by avoiding genome integration or 
through the use of excisable techniques.  
Adenoviruses are one of these approaches currently being studied as a possible 
alternative in gene delivery. Instead of incorporating the transfected genes into the 
host’s genome, the genes are directly expressed from the viral genome48. The main 
disadvantage of this strategy is the low efficiency obtained, most likely because the 
expression of the reprogramming transcription factors is not maintained during 
sufficient time to allow epigenetic remodelling49. Nonetheless, although less likely, the 
possibility of DNA integration is not fully discharged50.  
 
Other alternative being explored is the Cre-loxP system. In this technique the 
transfected gene is flanked on both sides by a sequence named loxP51, 52. Transient 
expression of the enzyme Cre recombinase will then allow the excision of the 
exogenous gene. A problem with this method is the possible remaining of a loxP site 
and few bases external to the loxP sites on the cell host genome. These could still 
affect the expression of the endogenous genes leading to an aberrant gene expression. 
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The Piggy Back transposon system is another viable option. A transposon is a 
genetic element that can change its position within the genome of a cell. Through this 
mechanism it is possible to deliver a particular gene without depending on viral 
vectors. The transposon can be integrated in the host chromosome in the presence of 
the enzyme Piggy Back transponase that targets the sequence TTAA. The gene can be 
later removed by the action of the same enzyme. The TTAA integration sites can be 
repaired after excision. The presence of this enzyme can be assured with the use of a 
helper plasmid with the respective coding sequence, mRNA sequences or the enzyme 
itself53.  
A major advantage of the Piggy Back system is the size of the genetic cargo that 
can be delivered. Lacoste and co-workers (2009) reported a Piggy Back system capable 
of delivering 18 Kb of genes in HESC54 while the typical viral system only allows a size 
of about 10 kb. 
 
Alternatively gene delivery can be replaced by the use of recombinant proteins 
that can be directly incorporated in the cell target55. The Oct4, Sox2, Klf4 and c-Myc 
proteins can be purified and combined with a poly-arginine peptide tag which allows 
them to pass through the plasma membrane of the cell after addition to the cell 
medium. This strategy was used on MEFs but had however low efficiency and required 
the use of the histone deacetylase (HDAC) inhibitor valproic acid.   
 
Strategies to improve the efficiency of reprogramming  
The reprogramming process is a very stressful event for the cell and can trigger 
DNA damage response resulting in cell cycle arrest and senescence. Several studies 
have reported an increase in efficiency when the DNA repair machinery was 
suppressed56-58. This may be one of the major causes that are on the basis of the low 
efficiencies achieved. However this is also a crucial step that helps to prevent 
chromosomal anomalies and aberrant gene expression. Additionally, the oncogenic 
nature of the transcription factors as agents in the induction of pluripotency is another 
problem59-61.  
A possible way to reduce the number of transcription factors without 
compromising the epigenetic remodelling during the process is the use of small 
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molecules that affect the access to chromatin. Huangfu and colleagues (2008) were 
able to reprogram human fibroblasts with only Sox2 and Oct4, using valproic acid 
(VPA)62. Other molecule with interesting features is BIX-0129, a G9a histone 
methyltransferase inhibitor. Shi et al, (2008) were able to reprogram neural progenitor 
cells (NPC) with only Sox2, Klf4 and c-Myc, by introducing this molecule in the culture 
medium63. The G9a histone methyltransferase is responsible for Oct4, Nanog and 
Dnmt3l repression during differentiation64, 65. 
Bay k 8644, a calcium channel agonist, has also been reported as having a 
positive effect at improving efficiency of cell reprogramming in MEF´s66. However the 
mechanism of action remains uncertain.  
 
Metabolism and reprogramming 
After this brief review of the agents that control gene expression in embryonic 
stem cells this thesis will address the impact of mitochondria and metabolism in 
pluripotency. The fundamental purpose of this work relies on the selection of a 
population of cord blood based on the mitochondrial phenotype. Therefore it is 
important to describe how metabolism is stemness related and how the signalling 
pathways related with mitochondria are changing during reprogramming.  
Recent findings have confirmed the important role of a metabolic adaptation as 
a requirement for the cells to undergo reprogramming to pluripotency67. Somatic cells 
rely mostly on oxidative phosphorylation for energy production while embryonic stem 
cells have a glycolytic metabolism. Therefore differentiated cells need to go through a 
metabolic shift during the reprogramming process. 
There are several metabolic features that are characteristic of embryonic stem 
cells: 
1. Embryonic stem cells are gathered from the inner cell mass of the 
blastocyst of pre implantation embryos. This means that they reside in a 
hypoxic environment without adequate levels of oxygen for oxidative 
phosphorylation. 
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2.  These cells have high sensitivity to the damage caused by reactive oxygen 
species (ROS). Since the cells will generate every tissue in the adult body, 
damage caused in the genetic material during this stage would be 
disastrous since would be perpetuated in the daughter cells. 
3. The absence of complete oxidation of glucose during the TCA cycle (or 
Krebs cycle) allows an increase of important substrates for biosynthetic 
pathways like amino acids, nucleotides and fatty acids.68 An example is the 
citrate used for synthesis of cholesterol and fatty acids. 
These properties need to be acquired during the reprogramming process for 
successful generation of iPSCs. Indeed, Andre Terzic and collaborators (2011) reported 
that the use of inhibitors of glycolysis (2-deoxy-glucose and 3-bromopiruvyc acid) 
lowered the efficiency or impaired the induction of pluripotency in mouse embryonic 
fibroblasts. Consistent with these results, the stimulation of mitochondrial function by 
piruvate dehydrogenase kinase inhibitor dichloroacetate also lowered the efficiency of 
the reprogramming process. Additionally, they reported that the metabolic shift was 
accompanied by an increase in mitochondrial membrane potential.17 
Mitochondria and metabolic pathways in pluripotency  
Mitochondria are organelles with a central role in metabolism as they are 
responsible for an increase in the production of energy derived from glucose through 
the process of oxidative phosphorylation. However the electron transport chain leads 
to the production of reactive oxygen species (ROS), which are important molecules 
that are a by-product of this pathway and have a major impact on cell structure 
integrity; the DNA in particular is very sensitive to oxidation. To avoid this, embryonic 
stem cells exhibit important differences in their mitochondria and when compared 
with differentiated cells they have higher antioxidant defences. Because they rely less 
on the oxidative phosphorylation pathway they have a more primitive mitochondrial 
phenotype, showing fragmented mitochondria, in small numbers with undeveloped 
cristaes and peri-nuclear localization. They have low amounts of mitochondrial DNA 
and low membrane potential67. 
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Recently, the role of mitochondria in reprogramming strategies has been 
gaining some attention from researchers. Important changes occurring during the 
reprogramming event have been documented. The important relationship between a 
glycolytic phenotype or low oxidative capacity and an increase in reprogramming 
efficiency has been observed.9 Indeed, as shown by Varum and co-workers (2011) 
(Figure 9), human IPS cells have a mixed phenotype between ESCs and somatic cells. 
Nonetheless, their metabolic state is closer to the ESCs. 
    Figure 9 – Morphologic features of mitochondria obtained by transmission electron microscopy in hESCs (WA07 line), IPSCs 
(IMR-90 IPSC line), and fibroblasts cells (IMR-90)69  
This metabolic shift is being described as crucial for cellular reprogramming. 
Therefore this part of the introduction will describe some of the metabolic pathways 
present in human cells that may be modulated during the reprogramming process. We 
give some examples of how these pathways impact in ESC cell biology and embryonic 
development. 
mTor/IGF-1 Pathway 
 
The mTor pathway has a relevant role in the control of pluripotency since it 
integrates signals from nutrients, hypoxia, energy status and the growth factor IGF-1. It 
is a complex network that allows the cells to adapt their activity based on changes in 
concentrations of substrates and avoiding to compromise critical cellular functions. 
(figure 10) 
Rapamycin is a drug that became known because of its ability to interfere with 
this important pathway that regulates metabolism, autophagy and ribosome 
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biogenesis as shown in figure 10. By binding to the FKBP12 protein it is able to perturb 
the functions of the mammalian target of Rampamycin (mTOR).  The mTor protein 
forms two complexes: mTor complex1 (mTORC1) composed of mTor, Raptor, AKTS1 
and mLST8 proteins and mTor complex2 (mTORC2) composed of Rictor, Sin1 and 
mLST1, which is not sensitive to rampamycin inhibition and interacts with the IGF-
1/AKT pathway. 
In an environment rich in energy (ATP) the mTORC1 binds to two proteins p70S6 
kinase 1 (p70S6K1) and 4E-BP1 in order to activate RNA translation. S6K1 activity leads 
to an increase of the cell size. The phosphorylation of 4EBP1 by raptor-mTORC1 
prevents inhibition of eIF-4e, which is important for translation of mRNA during cell 
division. The mTORC1 also inhibits autophagy, a mechanism responsible for the 
production of energy by catabolic breakdown of cellular components during starvation 
that is also important to remove damaged organelles.  
When the glucose, aminoacids and ATP levels are low LKB1 tumour repressor 
inhibits raptor-mTor by phosphorylating and activating AMPK. This mechanism is used 
to promote energy conservation and glucose uptake when the cells are exposed to a 
metabolic stress, typical in cells with a proliferative state. The AMPK activates a 
GTPase, the TSC2 protein, resulting in down regulation of Rheb protein and preventing 
it from activating mTORC1. 
In a hypoxic environment the hypoxia inducible factor 1 (HIF-1) induces the 
expression of REDD1, which in turn releases the TSC2 protein. This protein is 
responsible for mTORC1 inhibition.  
The mTORC2 has an important interaction with AKT/PKB, which is a key component 
of the PI3K pathway. PI3K pathway promotes cell survival and proliferation through 
inhibition of transcription factors of the FOXO class. Insulin Growth factor (IGF) is a 
hormone produced in the liver by stimulation of the growth hormone. When IGF-1 
binds to its receptor, the IGF-1R, the result is the activation of the PI3 kinase (PI3 K) 
and an increase of PIP3 in the plasma membrane. PIP3 will then activate PDK1 and 
mTORC2. Both these molecules will activate AKT, which will phosphorylate several 
proteins responsible for cell survival. 
Several transcription factors including AFX, FKHR, FKHRL1 from the Forkhead 
family, CREB and p53 are direct or indirect targets of Akt kinase. As members of the 
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Forkhead family they are implicated in the regulation of the cell cycle. The 
overexpression of AFX, FKHRL1, or FKHR causes growth suppression in a variety of cell 
lines70.  
 
 
 
 
Figure 10 – Signaling of the two branches the mTOR pathway by nutrients, hypoxia and growth factors. (adapted)71 
 
This pathway has been described as critical in mice embryonic development. 
The mTOR deficient mice die in the utero due to impaired proliferation.72, 73 
New insights point that the use of mTOR inhibitors (like PP242, rapamycin and 
resveratrol) may improve both speed and reprogramming efficiency. This mechanism 
accelerates the bioenergetic shift promoting mitophagy .74, 75 This is consistent with 
previous studies that suggest that an activation of p70s6k1 increases the levels of 
protein translation when pluripotent cells decide to undergo differentiation.76 Young 
et al 2009 have shown that autophagy starts with deactivation of the mTOR signal.77 
On the other hand, the overexpression of exogenous transcription factors 
(mediated by retrovirus) is thought to activate p53, leading to cell cycle arrest and 
apoptosis.78 This may also be prevented by mTOR inhibition (increased mitotophagy) 
which can be an important mechanism to reduce apoptosis and cell cycle arrest.74 The 
protein p53 mediates the apoptotic cascade and is capable to induce autophagy 
through induction of DRAM (damage-regulated autophagy modulator), a lysosomal 
protein, PUMA and Bax79, 80. 
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On the other hand, autophagy seems to be related with reports of 
accumulation of mid bodies in ESC and iPSC cells.81 Mid bodies are organelles formed 
during cytokinesis required for cell separation. After division they can be degraded by 
autophagy or accumulated and is suggested that they may have additional roles in 
determining cell fate. Apparently, these organelles accumulate in the daughter cell 
with the older centrosome during asymmetric division. This accumulation has been 
associated with the maintenance of stemness after division and with the reprogramed 
iPSC cells. Additionally induction of autophagy with rapamycin treatment led to the 
reduction of mid bodies in tumor cell lines (HeLa cells).82  
It is clear that the modulation of this pathway can be an important procedure 
that will benefit induction of pluripotency and the culture of iPSCs.  
 
HIF 
Human stem cells reside in environments with low concentrations of oxygen this 
may explain their high vulnerability to ROS. These reactive molecules may damage the 
DNA of the undifferentiated cell, which can result in a perpetuation of the lesions by 
cell replication. The modulation of the oxygen environment can therefore be an 
important factor in reprogramming technology. 
In response to hypoxia there is a change in gene expression mediated by hypoxia-
inducible factor (HIF)-1, that has an impact on cell survival, proliferation, apoptosis and 
glucose metabolism83 (Figure 11). This heterodimeric transcription factor is constituted 
by two proteins: the HIF-α, which has a oxygen dependent degradable domain, and 
HIF-β or ARNT which is insensitive to oxygen. Regulation of HIF activity is mediated 
through the stabilization of the alpha subunit. Under conditions of abundant oxygen 
HIF1-α protein is translated but is rapidly degraded. As oxygen levels decrease HIF1-α 
is stabilized and binds to constitutively expressed ARNT (HIF-β) subunits in the nucleus. 
The transcription and translation of HIF1-α remains unchanged by this mechanism, the 
difference in expression in hypoxia is only due to the stabilization of this protein that 
otherwise has a half-life of 5 minutes. The complex will bind to DNA and activate 
transcription through interactions with co-activators. 
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HIF-1a activation may also be induced by non-hypoxic stimuli. A possible 
mechanism involves the increase of translation of the HIF-1α protein through the 
mTOR/p70S6K and PKC (diacylglycerol-sensitive protein kinase C) pathways. PKC leads 
to gene transcription of the gene Sp1, which regulates the expression of HIF-1α. In this 
mechanism the rate of translation is increased while the degradation is unchanged. 
 
  
Figure 11 - Oxygen-dependent and independent regulation of HIF-1. In normal oxygen conditions, HIF-1_ is 
hydroxylated by PHD2, ubiquitinated by the pVHL complex and rapidly targeted to degradation by the proteasome. Non-hypoxic 
stimuli increase the transcription of HIF-1 gene by stimulation of PKC. The HIF-1 mRNA is then translated by increased activation of 
the PI3K pathway, which results in the increased HIF-1. Most non-hypoxic stimuli activate the PKC and PI3K pathways following 
binding with their associated receptors, which may explain the cell-type specific activation of HIF-1.83 
 
HIF-1 is responsible for the increase of many enzymes of the glycolytic pathway 
(table 2), as well as the glucose transporters 1 and 3 (GLUT1, GLUT3)84. Therefore it is 
expected to have a critical role in determining cell metabolism.  
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Table 3 - Target genes of HIF-1 and their function85  
 
An important gene activated in this pathway is the PDK gene, which encodes the 
pyruvate dehydrogenase (PDH) kinase (Table 3). PDK phosphorylates and inhibits PDH, 
the enzyme that converts pyruvate into acetyl coenzyme A (AcCoA) in the 
mitochondrial citric acid cycle, which generates reducing equivalents that are donated 
to the electron transport chain. As a result there is a decrease in the substrate for 
oxidative phosphorylation causing reduced ATP synthesis. By the other hand, there is 
an increase in glucose uptake via glucose transporters and increased conversion of 
glucose to lactate by the activity of glycolytic enzymes and lactate dehydrogenase A, all 
of which are encoded by HIF-1 target genes. 
This pathway is an important mechanism that adapts the synthesis of ATP in an 
environment with variations in oxygen concentration and without increasing the 
production of reactive oxygen species, being therefore relevant in reprogramming 
studies where a metabolic shift is essential. 
Numerous studies have reported benefits of culturing ESCs under low oxygen 
concentrations by reducing spontaneous differentiation, supporting self-renewal and 
decreasing chromosomal aberrations.86-89 Yoshida et al 2009 demonstrated that low 
oxygen pressure enhances the number of induced pluripotent stem cells generated in 
human and mouse cells.90 
Forristall et al 2010 have reported that ESCs cultured at 3-5% oxygen tension have 
an increase of Oct4, Sox2 and Nanog at mRNA levels when compared with the same 
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cells cultured at 20% oxygen tension. In ESC with HIF-2-α knockdown (a sub-unit of the 
HIF family) they described that the cells lost the capacity to mantain pluripotency, 
showing signs of differentiation with less clear borders and with areas with no 
expression of the pluripotent markers TRA-1-60 and POUF51.   Additionally they also 
reported that cells with all the three subunits of HIF-α (HIF-1-α; HIF-2-α and HIF-3-α) 
family knocked-down failed to generate colonies and survive in culture. 91  
All these insights point to the importance of this pathway to achieve/maintain 
pluripotency, suggesting its modulation is a tempting strategy to improve the 
efficiency of reprogramming. 
 
 
 
 
Motivation of this project 
 
As discussed before it is of great interest to select the population of cells more 
prompt for reprogramming. This is a fundamental step that lacks optimization in order 
to increase efficiency. A connection between the metabolism and mitochondrial 
phenotype in the achievement of pluripotency has been reported in fibroblasts; the 
mitochondrial status and cell immaturity seem to be indicative of reprogramming 
plasticity67. Our goal consists in finding if this connection holds true in cord-blood, by 
evaluating a possible relationship between the mitochondrial membrane potential and 
the kinetics and efficiency of reprogramming. In this work it is assumed that the 
mitochondrial potential is also related with mitochondrial mass92.  Based in this criteria 
we segregated two different populations of umbilical cord blood CD34+ cells based on 
mitochondrial membrane potential using TMRM, a cationic mitochondrial probe. We 
then monitored the number of colonies generated after delivery of Yamanaka’s 
transcription factors using a lentiviral system. Additionally, we also tested the effect of 
low oxygen concentration (hypoxia) in the development of iPS colonies. We evaluated 
the use of Antimycin A (inhibitor of complex III of the mitochondrial respiratory chain) 
to avoid reoxygenation each time that the cells were brought to normoxia to change 
the culture medium. Finally the colonies were characterized not only based on their 
morphology but also on gene expression, at the mRNA and protein level. 
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Methods 
  
Plasmid amplification 
The amount of DNA available for transfection was amplified in bacteria. The 
amplification was done separately for each plasmid. First 35µl (per transformation) of 
the bacteria Stbl3 Escherichia coli Chemically Competent were thawed on ice for 20 
minutes. Next we put 1 to 100ng of the plasmid to amplify in contact with 15µl of the 
bacteria solution. We applied a heat shock for 45 seconds at 42oC and 2 more minutes 
on ice. The heat shock was important to make the bacteria internalize the plasmid. We 
added 450µl of LB medium with ampicilin (100µg/ml) to the vial with bacteria and 
incubate them for 1 hour at 37oC on a shaker at 220 rpm (rotations per minute). The 
bacteria cells were put on the incubator at 37oC on a pre-warmed Petri dish with LB 
medium and ampicilin (100µg/ml) and agar to grow for 18 to 20 hours. As the plasmids 
contained a gene that conferred resistance to ampicillin, only the cells that internalized 
the plasmid survived. 
 We inoculated a single colony and put them on an Erlenmeyer with ampicillin 
(100µg/ml) and 150 to 200ml of LB medium. The solution stayed on a shacking 
incubator at 37oC and 220 rpm (rotation per minute). 
After 18 hours we collected the solution and centrifuged for 20 minutes at 
4000g and 4oC. 
 
DNA extraction  
 
The extraction of the plasmid from the bacteria was performed using a HiSpeed 
Plasmid Purification kit from Quiagen, as shown on figure 12. The pellet was 
resuspended with a vortex on 6ml of P1 buffer, a resuspension buffer that contains 
LyseBlue rom. The lysis of the bacteria was accomplished with addition of 6ml of P2 
buffer followed by manual agitation. This buffer has a detergent the SDS that binds to 
phospholipids and proteins of the bacteria membrane. As this buffer reacts with 
LyseBlue by turning the solution blue, this confirmed the homogeneity of the solution. 
After 5 minutes we added buffer P3 that neutralized the previously reaction and 
avoided plasmid denaturation. 
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The lysate was incubated 20 minutes at room temperature while forming a 
floating precipitate. We filtered the solution using an extraction kit filter and used 
buffer QC to wash the DNA contaminants from the bacteria lysis. The collection of the 
DNA was performed using buffer QF to a new sterilized falcon for DNA elution. We 
added 3,5ml of isopropanol and incubated the solution for 10 minutes allowing the 
DNA to precipitate. Finally we passed the solution by a precipitator ( QIA precipitator) 
also provided by the kit and collected the plasmid using mili Q water. The 
quantification of the DNA collected was done using a nanodrop device. 
 
 
Figure 12 Schematic representation of extraction of the DNA plasmids from a bacteria culture (adapted 
from QIA mini spin kit QIAGEN handbook) 
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Viral packaging 
  
The production of the third generation viral system was made by transfecting 
293T cells with 4 plasmids. We used 293T (Human Embryonic Kidney) cells because 
these cells are easy to grow and transfect. 
 The packaging set was divided on 3 plasmids to decrease the probability to 
generate a competent virus as a safety measure. As only plasmid with the transcription 
factors had the promoter that assured the reverse transcription it would be necessary 
a recombination of the 4 plasmids to generate a virus capable of replication.  
This vector construction was based on (Warlich, E. et al 2011)93.  
 
Figure 13 -Modular configuration of the self-inactivating (SIN) vector backbones for expression of the human (h) reprogramming 
factor (RF) Oct4, Klf4, Sox2, and c-Myc,.  marks the SIN configuration with partially deleted U3 of the 3′ long terminal repeat. 
cPPT, central polypurine tract;  FP, fluorescent protein dTomato;) IRES, internal ribosomal entry site; nuc, nuclear membrane-
localized derivative; PRE, post-transcriptional regulatory element; RRE, rev-responsive element; RSV, Rous sarcoma virus U3 
promoter; SA, splice acceptor; SD, splice donor; SFFV, spleen focus-forming virus promoter; packaging signal. (adapted from 
Warlich, E. et al 2011)93 
 
IRES allows the recruitment of ribossomes to the middle of the mRNA molecule. 
This will result on alternative splicing which is the ability of a single mRNA to code 
multiple proteins with different function and sequence. The RSV promoter is naturally 
silenced since the virus is SIN (self inactivating), only the SFFV promoter is involved in 
the expression of the reprogramming genes. During the reprogramming the cell 
undergoes an epigenetic remodelling leading to silence of the SFFV promoter. 
Consequently the exogenous pluripotent genes and the gene coding for d’Tomato 
fluorescent red protein will cease to be expressed which can be monitorized on a 
fluorescent microscope. For this reason it is possible to correlate the fluorescence of 
the colonies with induction of pluripotency. 
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The main plasmid expressed the 4 Yamanaka’s transcriptional factors (Oct4, 
Sox2, c-Myc and klf4) and a d’Tomato protein as a fluorescent marker. The promoter 
used was SFFV (spleen focus forming virus). In case of epigenetic remodelling the 
promoter would be recognized as exogenous to the cell being silenced which results in 
loss of fluorescence by the Tomato protein. This was a practical tool to help 
characterization of the colonies. The other 3 plasmids were used for packaging in order 
to create a self-inactivating replication incompetent virus: pcDNA3.GP.4xCTE 
expressing HIV-1 gag/pol;  pRSV-Rev (enconding both a nuclear localization signal, for 
the pre integration complex, and a nuclear export signal for the viral RNA exit the 
nucleus before degradation); and  pMD.G encoding the vesicular stomatitis virus 
glycoprotein (VSVG). 
 
The cryovials with 293T cells were thawed, and the cells were grown in t75 
flasks with a specific medium: DMEM ( Dulbecco's Modified Eagle´s Medium from 
GIBCO/Alfagene), 10% FBS (Fetal Bovine Serum from GIBCO/Alfagene) and PenStrep 
(Penicillin-Streptomycin Mixture from Lonza/VWR). We only proceed with the 
transfection after the t75 flasks have reached about 80% confluence. 
 
Figure 14 - Schematic representation of the viral production on 293T cells. (adapted from 
https://www.openbiosystems.com/Viral%20Packaging/TransLentiviral%20Packaging%20Syst/) 
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We used different concentrations of each plasmid as shown on table 4: 
 
 
 
Plasmid Concentration 
pRSV-Rev 5µg 
pcDNA3.GP.4xCTE 13 µg 
pMD.G 3,75 µg 
Lentiviral vector 13 µg 
Table 4– Plasmids concentration used on transfection. 
 
 To insert the plasmids on the 293T we used the calcium phosphate method. 
First we mixed our plasmids with calcium chloride (2,5M). Then we dropped the 
solution drop by drop on a tube containing HBS (HEPES-buffered saline) (1M). The 
mixture formed a precipitate of calcium phosphate and DNA. As the DNA and the cell 
membrane have a negative charge, this method allows overcoming the charge 
repulsion. As the solution was put in contact with the 293T cells the precipitate 
attached to the cell membrane and entered the cell by endocytosis94. 
 After 5 hours we changed the medium. At 72 hours after the transduction we 
collected the medium containing the virus. The medium was filtered using a 0,45µm 
low binding protein filter and was centrifuged 3h at 22500 rpm at 10oC for 
concentration. We made aliquots of the virus diluted on 20 µl of DMEM and store 
them at -80oC. 
 
Viral titration 
  
 We calculated the number of infectious units (IU) per ml on our virus. To access 
this number we plated 293T cells on a 6 well plate that was incubated at 37oC 
overnight. On the next day we changed the medium and infected each well with 
different volumes of our stock virus: 2,5µl; 5µl; 10µl; 20µl and 50µl. Cells were 
incubated at 37oC for 18 hours after which we washed the cells 2 times with PBS and 
added new medium. We incubated cells at 37oC for 48 hours. Finally we counted the 
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number of infected cells on fluorescent microscope. The number of IU was calculated 
by the following formula: 
 
)
)%
(
usedvirusstockuL
cellspositivecellsnrinitial
IU

   
 
CD34+ isolation 
 We isolated the CD34+ cells from human umbilical cord blood with a protocol 
optimized in our laboratory. First we diluted the blood in the same volume of a dilution 
medium (2mM of EDTA, in PBS (Phosphate-buffered saline) with 7,2 pH ). The EDTA in 
this solution is used to avoid cell aggregation and coagulation of the blood. We put the 
mixture in a falcon with one third of the final volume in Lymphoprep. Lymphoprep is 
used to achieve a density gradient separation during centrifugation.  
We centrifuged the sample at 400g during 35minutes, with no brakes at 20oC. 
After this step the solution was separated in several layers. (Figure 15) 
 
 
Figure 15– Schematic representation of the separation in layers through density gradient. 
 
We aspirate the layer containing the CD34+ cells and discharged the remaining 
layers. Cells were centrifuged at 300g for 10 minutes at 20oC and the supernatant was 
discharged. To completely remove the platelets we resuspended the cells on 50ml of 
MACS buffer (0,2 mM of EDTA, 0,5% BSA, and 5,7mM of NaOH in PBS with 7,5 pH)and 
centrifuge the cells 450g for 15 min at 20oC. We repeated this step one more time.  
To isolate the cells with CD34 marker we used magnetic assorted cell sorting 
(MACS). 
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The cells were resuspended on 320µl of the MACS buffer and it was added 
100µl of CD34 MicroBeads and 100µl of FcR blocking agent. The MicroBeads are 
attached to an antibody specific to the CD34 membrane receptor. The FcR blocking 
agent is used to eliminate unspecific interactions between the MicroBeads like beads 
aggregation. 
The cells stayed in contact with the beads for 30 minutes at 4oC with mixing 
every 10 minutes. We centrifuged the cells for 10 minutes 300g at 4oC and 
resuspended them on 3ml of MACS buffer. 
We calibrated a magnetic column with 3ml of the dilution buffer and pass the 
solution with cells three times through the column. Only the cells that had the 
MicroBeads attached to the cell membrane remained on the column as the others 
were washed to a recover tube.  
In the end we remove the column from the magnet and recovered the CD34+ 
cells with 5ml of the dilution buffer. 
We diluted and counted the cells with a hemocitometer. The cells were 
centrifuged 300g for 10 minutes at 4oC and were left overnight on StemSpan medium 
(bovine serum albumin (BSA), recombinant human insulin, iron-saturated human 
transferrin, 2-mercaptoethanol and supplements in Iscove’s Modified Dulbecco’s 
Medium (IMDM)) with cytokines (SCF (100ng/ml), Flt-3(100ng/ml)). The StemSpan is a 
medium specific for hematopoietic stem cells. The cytokines used stimulate the 
proliferation of these cells95, 96. 
 
 
Fluorescence-activated cell sorting (FACS) with TMRM 
 
On the following day of the CD34+ cells isolation, we proceeded with antibody 
labeling. We used TMRM (Tetramethylrhodamine, Methyl Ester, Perchlorate from 
Invitrogen), a lipophilic cationic mitochondria probe that is sequestered by the 
mitochondria according to the membrane potential. Cells that rely on oxidative 
phosphorylation have a higher mitochondria membrane potential which we hoped to 
correlate with differences in the reprogramming efficiency.  For maximum purity the 
cells were also labelled with anti CD34 antibody (10µl; miltenyi biotec). 
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 We prepared a stock solution of TMRM in DMSO.  We diluted the TMRM 
solution in PBS, in order to obtain a final concentration of 2,5nM on the medium 
containing the CD34+ cells. Cells were put in contact with the dye and were incubated 
for 10 minutes at 37oC. In order to proceed with the CD34 labeling we centrifuged the 
cells at 300g for 5 minutes, washed 1 time with PBS and resuspended them on 0,1ml of 
PBS with 10% FBS (Fetal Bovine Serum). We added 5nM of CD34+-FiTC antibody and 
incubated the cells for 10 minutes at 4oC. Finally we resuspended the cells on 10 ml of 
PBS (with 10% FBS). 
 
 We also prepare the following controls:  
Cells only 
Cells with CD34+ antibody only  
Cells with TMRM only 
Table 5 – Sample conditions 
 
As the CD34-FiTC emits around 525 nm the gate was set in fl3 channel to see 
this fluorescence while the TMRM was analysed on the PE channel. The sorting was 
performed on a FACSAria sorterfrom BD Biosciences. 
After sorting the cells were collected in StemSpan medium and stayed 
overnight at 37oC in a 6 well plate. 
 
 
Characterization of high and low TMRM populations – CD34, CD15, CD45 and 
CD133 markers 
 
On a parallel experiment we compared the expression of different markers to 
confirm if the different uptake of the TMRM probe was sufficient to correlate with 
different maturation stages of the cells. We marked cells with the antibodies: CD34  
Percp cy5.5 BD (10µl; BD Biosciences), CD15-FITC (2,5 µl; BD Biosciences), CD45 Pacific 
Orange (2,5 µl; Invitrogen)and CD133 –APC (10µl; miltenyi biotec).  
 
   
Viral transfection 
After sorting we had two populations with distinct membrane potential which 
was correlated with the mitochondria membrane potential.  
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The method of transfection was based on (Giorgetti, A., N. Montserrat, et al. 
2010)96. First we coated 24 well plates with retronectin. This procedure improves viral 
infection by attaching the viral particles to the bottom where the cells were seeded. 
We putted retronectin (15µg/cm2) on each well of the 24 wells plate and incubated it 
for 2 hours at room temperature. We remove the retronectin and putted 500µl of PBS 
with 2% BSA (Bovine serum albumin, from Sigma-Aldrich) on each well and incubated 
for 30 minutes at room temperature. BSA is used as a blocking agent to make sure the 
virus only attaches on a coated surface. We removed the BSA solution and washed one 
time with PBS. 
We thawed aliquots of the virus in Dulbecco's Modified Eagle Medium DMEM 
(500µl for each well with retronectin) and added 1µl of polybren. The polybren 
interacts with the viral protein increasing the charge at its surface. As the cell 
membrane is negatively charged the transport through the membrane is facilitated in 
molecules positively charged. We centrifuged the plate for 1 hour at 2000g and 32oC. 
This step was required for the attachment of the viral particles on the retronectin coat. 
The viral supernatant was removed and washed with 1ml of PBS taking care that the 
virus bound to the retronectin did not dried out. 
On the first experiment we collected the CD34+ cells from each condition and 
put about 108000 cells with the high mitochondrial potential condition (high 
population) in a well of a 24 well plate and 160000 of the low mitochondrial potential 
(low population) on a similar well, both with a retronectin coating. We infected the 
cells a second and a third time with 12 hours between each infection (Giorgetti, 2010). 
On the last two infections we carefully removed the 500µl supernatant to avoid cell 
removal and replaced it with 500µl of thawed virus solution and the 1µl polybren.  
 
Inactivation of MEFs (Mouse Embryonic Fibroblasts) 
 
Culture of Human embryonic stem cells requires a feeder layer that can provide 
β-FGF to the medium. This factor is involved on wnt and  Activin/Nodal pathways, 
inhibiting differentiation97 and stimulating pluripotent genes like Oct498.  
MEFs were cultured and expanded in t75 flasks coated with 0,1% gelatin 
(0,1g/100ml PBS) in MEF’s medium: DMEM (Dulbecco's Modified Eagle´s Medium from 
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GIBCO/Alfagene), 10% FBS (Fetal Bovine Serum from GIBCO/Alfagene) and 0,5% 
PenStrep (Penicillin-Streptomycin Mixture from Lonza/VWR) (10000 U). When the 
flasks became confluent, the cells were inactivated with mitomycin C at 37oC for 2 
hours. Mitomycin C is a DNA crosslinker that suppress cell division. 
Inactivated MEFs were plated in a gelatin coated 6 well plate (0,1%) on the day 
of the last  infection of the CD34+. 
 
IPS cells culture (normoxia) 
 
 The CD34+ cells were passed to inactivated MEFs on a pre treated gelatine 
coated 6 well plate 24 hours after the last infection with 2ml of HES medium: Knockout 
Dulbecco’s Modified Eagle Medium (78,3%, from invitrogene); Knockout serum (20%), 
Non essential aminoacid solution (1%); 2-mercaptoethanol (0,2%); L-glutamine (0,5%); 
bFGF (0,05%) and 0,5% PenStrep (Penicillin-Streptomycin Mixture from Lonza/VWR) 
(10000 U). After 48 hours the HES medium was replaced daily with careful to not 
resuspend the cells. On the first experiment we seeded about 108000 cells of the high 
TMRM uptake and about 160000 of the low TMRM uptake on a 6 well plate with MEFs. 
About 10000 cells were seeded per well on a 6 well plate on the following 
experiments. The morphology of the colonies was observed at the optical microscope 
after the daily medium change.   
 On the first experiment after 7 days in culture with MEFs the wells were 
confluent and were passed from 1 to 3 wells with MEFs pre inactivated with gelatine 
coating. On the following experiments that involved conditions in normoxia the cells 
were not passed. 
 
IPS cells culture (hypoxia) 
 The Low and high cells were seeded on a 6 well plate (10000 cells per well) with 
matrigel (from BD Biosciences) 24 hours after last infection and supplemented with 
conditioned medium in a 0,5% O2 and 5% CO2 environment. Conditioned medium is 
HES medium used in culture of MEFs for 24 hours. This medium contains important 
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factors that help avoid hESC to differentiate such as FGF2 and BMP inhibitor GREMLIN 
1.99, 100The medium was changed on day 8 and 14 after the last infection.  
 On the last experiment to access the effect of an mitochondria respiratory 
chain inhibitor, we added 2nM of antimycin A (Sigma-Aldrich, ref: 8781) to the 
conditioned medium of both samples high and low.  
Monitorization of the reprogrammed colonies 
Both conditions were analysed using photographies taken with a fluorescent 
microscope during 12 days after the last infection. We evaluate the efficiency of 
reprogramming in both populations by comparing the number of non fluorescent 
colonies with the number of infected cells 48 hours after the last infection. 
Furthermore the average  size and the number of fluorescent colonies were also 
estimated using ImageJ software.  
RT - PCR 
 To access the mRNA of the colonies was done a reverse transcription reaction 
to obtain cDNA. We extracted mRNA from the cells using trizol. The isolation of the 
mRNA was done with an extraction kit (QiAGEN RNAesy®).  
After purification, the mRNA was used to produce the cDNA, using Taq –
TaqMan kit from invitrogen. the enzyme reverse transcriptase, water, random 
oligonucleotides, MgCl2, RNA inhibitor, dNTPs and the RNA template in a termocycler 
for 45 minutes: 10 minutes 25oC; 30min 48oC and 5min 95oC. 
To access the gene expression was performed a real time polimerase chain 
reaction (RT-PCR) in Fast Real-Time PCR System from Applied Biosystems. The 
conditions of the real time PCR cycle are presented in table 7. 
We compared the expression of Sox 2, Oct 4 and Nanog in both populations 
using as housekeeping gene, the GAPDH gene expression. The primers used are listed 
below: 
 Volume used (µl) 
Primer forward  2,5 
Primer Reverse  2,5 
Mix-Power SYBR Green Master (life 
technologies from applied biosystems) 
12,5 
H2O 5 
cDNA 2,5 
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Table6 – Volumes of each component added to perform the RT-PCR  
 
 
Cycle  Cycle conditions (time and temperature) 
Denaturation of the DNA chain step (1 time) 94–98 °C for 5minutes 
Annealing step (40 times) 94 °C for 30 seconds, 60°C for 30 seconds and 
72°C for 33 seconds 
Elongation step (1 time) 72 °C or 7 minutes 
Final elongation (1 time) 95 °C for 15 seconds, 60°C for 1 minute and 
95°C for 15 seconds 
Table 7 – Cicle conditions during the RT-PCR 
 
Oligo name sequence (5’-3’)  
NANOG-For (Forward Nanog) 
NANOG-Rev (Reverse Nanog) 
SOX2-For (Forward Sox2) 
SOX2-Rev (Reverse Sox2) 
OCT-4-F-Con (Forward Oct4) 
OCT-4-R-Con (Reverse Oct4) 
GAPDH-F (Forward GAPDH) 
GAPDH-R (Reverse GAPDH) 
FH2_PFKM (Forward Human 2 PKFM) 
TCTCCAACATCCTGAACCT 
GCGTCACACCATTGCTAT 
GATGGTTGTCTATTAACTTGTTCA 
TCTCTCCCTTTCTTTCTCTCT 
GTGGAGGAAGCTGACAACAA 
CTCCAGGTTGCCTCTCACTC 
AGCCACATCGCTCAGACACC 
GTACTCAGCGCCAGCATCG 
TTTATTCCTGAATGTCCACC  
RH2_PKFM (Reverse Human 2 PKFM) CAGATTCTTGATGTCTTCTGAG  
FH1_LDHA (Forward Human 1 LDHA) CACCATGATTAAGGGTCTTTAC 
RH1_LDHA  (Reverse Human 1 LDHA) AGGTCTGAGATTCCATTCTG 
FH2_HK2 (Forward Human 2 HK2) GAAAGCAACTGTTTGAGAAG 
RH2_HK2 (Reverse Human 2 HK2) 
FSLC2A1 (Forward Glut1) 
RSLC2A1 (Reverse Glut1) 
CAATGTCTGAGATGTCTTTGG 
GAGACACTTGCCTTCTTC 
GCTTTGTAGTTCATAGTTCG 
Table 8 – Primers RT PCR for low and high population (obtained from SIGMA- ALDRICH). 
We evaluated the mRNA content of Oct4, Sox2, LDHA, HK2, PKFM, Glut1 and 
NANOG on high and low populations cultured in normoxia on the first experiment.  
 We also checked if the metabolic footprint of CD34+ cells could be correlated 
with the TMRM uptake. This was done by evaluating the mRNA of genes on which high 
expression is associated with increased glycolysis rate (HK2, LDHA and PKFM). HK2 
(hexokinase II) is a gene coding an enzyme that is responsible for the glucose uptake by 
the cell. PKFM codes for a crutial step on glycolysis where fructose-6-phosphate is 
converted to fructose-1-6-bisphosphate. LDHA is an important gene that codes an 
enzyme convert piruvate in lactate regenerating NADH and preventing it from entering 
on krebs cycle. 
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Western Blot 
We evaluated gene expression on high and low cells of the first experiment 
cultured on normoxia conditions at the protein level to confirm the increased 
transduction of the pluripotent genes in the reprogrammed cells. 
After the extraction we quantified the levels of protein in each sample using 
Protein Standard, Micro Standard (BSA quantification Kit) from Sigma-Aldrich, using 
BSA as protein standard for calibration purposes. This step was important to make sure 
that all the samples had the same amount of protein before running the gel. The gel 
used to run our samples was NuPAGE 4-12% Bis Tris Gel 1.0 mmx10 well (ref: 
NP0321PK2) from novex by life technologies. We accessed the levels of Oct4 and Sox2, 
using β actin as a reference protein. The antibodies and incubation conditions were the 
following: 
 Oct4 (primary antibody - mouse) – Oct3/4 (C-10): catalogue sc-5279 
from Santa Cruz Biotecnology, inc. (1:500, incubated for 16 hours) 
 Sox2 (primary antibody – rabbit) – catalogue AB5603 from Millipore 
(1:1000, incubated for 16 hours) 
 The secondary antibodies belonged to the kit ECF Western Blotting 
Reagent Pack (mouse and rabbit) 2nd Antibody - GE HealhCare.  
(1:5000, incubated for 1 hour). 
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Results and Discussion 
 Since the beginning of this work we were interested in exploring new 
approaches that could help to improve the results of reprogramming studies. We 
focused our strategy in developing an alternative method to efficiently select the cells 
within the cord-blood population that were more suitable for this purpose.  
 Our line of thought was based on the idea that the metabolic phenotype could 
be directly correlated with cell maturity. Using the mitochondrial probe TMRM 
(reporter of mitochondrial membrane potential) we segregated two different 
populations within the cord blood CD34+ population. By delivering the Yamanaka 
genes (OSKM) in a lentiviral vector we successfully achieved reprogramming with 
distinct efficiencies. We confirmed that the sorted populations were indeed different 
with respect to their stemness after phenotypic characterization of the 2 populations 
with cell surface antibodies. Additionally we tested reprogramming in hypoxic 
conditions and the use of a respiratory chain inhibitor in an attempt to further increase 
efficiency. It was interesting to find that both hypoxia and the treatment with the 
mitochondrial inhibitor not only increased the reprogramming efficiency of the less 
immature population but also equalized efficiencies and gene pattern expression 
between the high and low TMRM populations.  
 
Cell sorting 
The cells with normal size, internal complexity and higher expression of the 
CD34 marker were sorted according with the uptake of TMRM 
(Tetramethylrhodamine, methyl ester; invitrogen). TMRM is a cationic probe that is 
sequestered by active mitochondria. If the mitochondria is polarized, which happens in 
oxidative phosphorylation by the existence of a proton gradient, the matrix has a 
negative charge. As the probe has a positive charge it will be in higher concentrations 
inside the active mitochondria. (Figure 16) 
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Figure 16 – Uptake of the TMRM probe according to the polarization of the mitochondrial membrane caused by the 
proton gradient. (Adapted from Vian Azzu et al 2010)  
 
TMRM titration 
Magnetic-bead isolation of the CD34+ cord blood cells was done using the 
Miltenyi technology. These cells were then sorted based on the uptake of the 
mitochondrial probe TMRM (Tetramethylrhodamine, methyl ester; invitrogen). This 
way we expected to compare the efficiency of reprogramming in 2 populations with 
different mitochondrial phenotypes.  
In a first trial we used 25nM concentration of TMRM to label the CD34+ cells. 
This caused an overload of TMRM in the cells and this unspecific uptake could not be 
correlated with mitochondrial membrane potential. The fact that all cells were 
showing a high signal was indicative that the TMRM probe had a narrow dynamic 
range at this concentration (figure 17a).  
For determination of the optimal concentration to use in CD34+ cells we did a 
titration with mononuclear cells using several concentrations of TMRM (1nM; 2,5nM; 
5nM; 10nM; 20nM). The concentration that showed the best compromise between 
positive signal and wide dynamic range was 2,5nM and this was used for the rest of 
the experiments (figure 16b). 
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a b  
Figure 17a and b – a) scatter plot of TMRM labelled CD34+ cells from cord blood before titration. Since the concentration was too 
high this made most of the cells to have a similar high uptake of the probe, making impossible to distinguish between the two 
phenotypes. b) after performing a titration and using a 10 times lower concentration it was possible to identify 2 populations with 
different uptakes and thus different mitochondrial phenotypes 
 
Sorting the CD34+ cells 
After CD34+ isolation using MACS protocol it was possible to collect 2 million 
cells from one blood bag. After sorting, cells with low TMRM uptake (low population) 
and cells with high TMRM uptake (high population) were obtained; the narrow gates 
used can explain this reduced number of cells. Our aim was to compare only the 
extremes of both phenotypes. 
 
 
a  b  
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c  d  
 
Figure 17a, b, c and d- Scatter plots from flow cytometry on CD34+ cells; a) selection of a population based on the volume and 
internal complexity discharging contamination from beads, differentiated cells and cell debris; b) we further select the cells that 
had a higher expression of CD34 marker; c) The cells that had higher expression of CD34 marker were sorted based on the 
mitochondria phenotype: the cells that had lower uptake of the cationic probe TMRM and the cells with higher uptake. This 
uptake is correlated with mitochondria polarization; d) percentage of cells in each phenotype selected. 
Reprogramming efficiency: TMRM Low versus TMRM High populations 
The cells with lower uptake of the TMRM probe upon sorting were easier to be 
reprogrammed; this was patent by the appearance of more non-fluorescent colonies 
along the time in this population, when compared with the high TMRM population. To 
evaluate the efficiency of reprogramming, we counted the colonies that did not 
express the fluorescent reporter (d’Tomato protein) and compared them with number 
of cells infected in the beginning of the process. The viral vector used a retroviral 
promoter that is not expressed in human hematopoietic stem cells. During the 
epigenetic remodelling that occurs upon reprogramming the promoter is recognised as 
strange by the cellular machinery and silenced.93 This event assures that the 
transcription factors expressed in non-fluorescent colonies have an endogenous origin, 
being activated by the auto regulatory loop of the main pluripotent genes.  
The lower uptake of TMRM seems to be correlated with a more primordial 
phenotype of the mitochondria, with slightly polarized membranes. These cells rely 
mostly on glycolysis to generate ATP and this explains their low membrane potential; 
the opposite phenotype is characteristic of more differentiated cells where the 
mitochondrial membrane is more polarized due to the proton gradient of oxidative 
phosphorylation.69 Indeed, human embryonic stem cells are also glycolytic and also 
57 
 
show this mitochondrial phenotype. Since reprogramming seems to be affected by 
stochastic events, choosing a population within cord-blood that more closely 
resembles the embryonic stem cell characteristics seems to be an important step to 
increase final efficiency. 
These results seem however contradictory with the report of Folmes et al 
(2011), where the increase in mitochondrial membrane potential correlated with a 
higher efficiency of reprogramming. We believe that the metabolic profile of the cells 
before induction of pluripotency can explain these discrepancies. The rise in TMRM 
uptake in mouse embryonic fibroblasts (MEFs) described by these researchers is 
probably related with the metabolic shift that these cells must undergo during 
reprogramming.  MEFs rely on the mitochondrial electron transport chain to produce 
ATP while the ESC and iPSC use a glycolytic metabolism. In order to undergo this 
metabolic shift MEFs require the shutdown of the mitochondrial electron transport 
chain machinery. This will let them exposed to a high concentration of ROS produced 
by electron leakage from the electron transport chain. These ROS should be the ones 
responsible for the increase of membrane potential reported. 
 On the other hand, hematopoietic stem cells are mostly glycolytic so they do 
not require a metabolic shift to reprogram. Thus it is not expected, in this case, the 
correlation between higher polarization of mitochondria and reprogramming 
efficiency. 
 
Figure 18 – Number of reprogrammed colonies per mm2 on high and low populations. The number of reprogrammed 
colonies was approximately the double in the low TMRM population.  
The first non-fluorescent colonies (reprogrammed) were documented in the 
low TMRM population. As there was no fluorescence of the Tomato protein we 
0
0,5
1
1,5
11n
u
m
b
e
r 
/m
m
2
days after infection
Number of reprogrammed 
colonies
low TMRM
high TMRM
58 
 
concluded that the viral promoter was already silenced and the embryonic features 
were maintained by the expression of the endogenous factors. The bigger number of 
colonies that underwent epigenetic remodelling was achieved in the low TMRM 
population (figure 18).  
 
 
Figure 19– Diameter of the reprogrammed colonies 11 days after infection. The difference was not statistically relevant. 
The diameter of the colonies was practically the same in both conditions 
indicating similar proliferative rates (figure 19). 
 
Morphology of the colonies 
Human ESCs (Embryonic Stem Cells) colonies are characterized by high 
nucleus/cytoplasm ratio, round shape, compact appearance, and with well defined 
borders as shown in figure 20.2, 101 The colonies generated from the low TMRM 
population (figure 21) had closer morphology to ESCs than the cells from the high 
population (figure 22). 
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 Figure 20 - Human embryonic stem cell colony. (adapted from 
http://www.stemcellresearch.umich.edu/news/photos.html).  
On the other hand the colonies from the high population showed sign of 
disintegration and the exogenous genes were not fully silenced as shown by the 
presence of cells expressing the red fluorescence reporter. Both conditions showed 
however some degree of differentiation at the borders.  
a   b  
c  
Figure 21 a) b)  Non fluorescent colonies 12 days after the third infection. a) Cells of the low TMRM population showing some 
differentiation at the borders of the colony but compact and round shape at the centre. b) Fluorescence emission channel photo 
showing no signs of d’Tomato expression. c) Merge of the photo a and b.   
 
Nevertheless, it is important to report that in this first experiment we 
encountered a major obstacle in our analysis method. We started with a cell density 
per well that was higher than optimal (~100000 cells per well of 6-well plate) and 
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because of that during proliferation of the colonies we noticed that they started to 
touch neighbour colonies. Faced with the dilemma of the passage of the colonies, we 
decided to pass them to avoid differentiation. As our purpose was to compare the 
number of colonies generated in both conditions, the passage of the cells may have led 
to disintegration of some colonies compromising final analysis. (figure 22). 
a  b  
c  
Figure 22 a) and b) Cells of the high TMRM population 12 days after the third infection. a) the cells are less compact, more 
heterogeneous and show signs of disintegration. B) the fluorescent channel show signs of expression of the exogenous genes on 
some cells pointing to failed reprogramming . c) Merge of the photo a and b.   
 
Efficiency – Low TMRM population was more efficient 
Our evaluation of the efficiency was made by comparing the number of 
reprogrammed colonies (not expressing our reporter) with the initial number of 
infected cells on the day following the infection using the fluorescent microscope 
(58000 on the low TMRM uptake and 56000 on the high TMRM uptake condition). This 
way we estimated from our photos how many cells that had the exogenous genes 
initially integrated on their genome and were able to give origin to colonies with ESC 
like morphology and with the exogenous genes silenced.  
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Figure 23 – Efficiency of reprogramming on both populations 11 days after the last infection. The error in the graphic is 
the standard error.  
 
The efficiency of the low TMRM population was practically the double of the 
high population on the last day of reprogramming. (figure 23) 
We were able to achieve a better efficiency than the ones reported in the 
papers where we based our strategy in93, 96. An obvious explanation for this 
discrepancy is the type of cells used for reprogramming. As CD34+ cells are more naive 
than MEFs they require less epigenetic remodelling to achieve pluripotency. Other 
important reason is related with the use of a polycistronic virus that contained all 4 
Yamanaka’s factors instead of only 2 (Oct4 and Sox2) as in (Giorgetti, A. Et al, 2010), 
reinforcing the importance of c-Myc and klf4 to improve the efficiency of the process. 
 Another point has to be taken in account as the initial number of infected cells 
was counted only 2 days after infection instead of the following day. This could have 
interfered in the calculi of the final efficiency because of cell proliferation in culture. 
Finally it is important to note that we could be introducing a considerable error by 
using our method to count colonies. As we only took 10 photos using fluorescent 
microscope for each well. After this we calculated the average number of colonies per 
photo and with this number we estimated the number of colonies per mm2.  
 
Phenotypic characterization of the low and high TMRM populations 
Since the best results were obtained in the low TMRM cells we decided to 
further characterize this population. Although we had assumed that there should be a 
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relationship between cells with lower uptake of TMRM and a primordial mitochondria 
phenotype we needed to confirm the immaturity of these cells. We cannot exclude the 
possibility that the signal obtained by the TMRM probe can be affected by 
mitochondrial mass, as cells with more mitochondria and less mitochondrial 
membrane potential can display similar levels of TMRM than cells with less 
mitochondrial mass but higher mitochondrial membrane potential. On the other hand, 
the immature cells of the CD34+ population could be more effective at “pumping out” 
the TMRM probe affecting the correlation between mitochondrial phenotype and 
TMRM uptake. Indeed, the staining of CD34+ cells with rhodamine mitochondrial 
probes (Rh-123) was found to be more effective using P-glycoprotein (P-gp) inhibitors. 
P-gp is an efflux pump that is highly expressed in hematopoietic progenitors and Rh-
123 along with other dyes is substrate for transport mediated by P-gp through the 
membrane. Higher expression was associated also with cells displaying characteristics 
of pluripotent stem cells.102  
We immunolabelled cells with CD133, CD45 and CD15 antibodies to see if 
TMRM signal was somehow correlated with different phenotypic sub-populations of 
CD34+-cells. The CD133 is a primitive hematopoietic marker and is expected to have 
higher expression in the most immature population. 
 
Figure 24 – Scatter plot from flow cytometry of the CD34+ cells. The cells were marked with TMRM probe and two 
different populations were selected according with their uptake. We isolated 17,7% of the cells of the CD34+ pool with low TMRM 
uptake and 17,5% with high uptake. The yellow cells have low uptake (low population) and the blue have high uptake (high 
population). 
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The CD133- CD34+ cells consist mainly on B-cell progenitors and erythroid 
progenitors 103. On the other hand the CD15 and CD45 markers are related with 
differentiation commitment. While the CD45 marker is associated with myeloid 
commitment (granulocytes, basophiles, eosinophils)104 the CD15 is highly expressed in 
the neutrophile population105. 
 
a  b  
Figure 25 – scatter plot from flow cytometry. a - Expression of the CD15 marker on the CD34+ population. The low 
yellow cells have low TMRM uptake and the blue cells have high TMRM uptake. The higher expression of this marker in the high 
TMRM population is a sign of neutrophile commitment. b- Expression of the CD45 myeloid marker. Although both populations 
show a great expression of this marker, it is again possible to confirm a higher differentiation commitment within the high TMRM 
population.    
c  
Figure 25c – Expression of the primitive marker CD133. In accordance with the previous results the primitive marker 
CD133 is more expressed in the low population. 
The results obtained by flow cytometry analysis were clearly showing the 
existence of a different degree of stemness between high and low TMRM populations 
(figures 24 and 25). It was also possible to confirm that the low population has a more 
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primitive phenotype (higher CD133), which is in accordance with the results obtained 
in terms of reprogramming efficiency. 
 
Gene expression characterization of the reprogrammed colonies 
RT-PCR confirmed the higher expression of the pluripotent genes Nanog, Oct4 
and Sox2 in the reprogrammed colonies of the low TMRM population. 
 
Figure 26 – Graphic showing the fold induction of Oct4 gene of 11 days reprogrammed colonies of high and low 
samples. Low cells have 18 times more Oct4 mRNA than CD34+ cells and 9 times the level on the high population. Fold induction 
was normalized with CD34+ population. *P<0,05 (P= 0,001106) 
 
 
 
Figure 27 – Graphic showing the fold induction of Sox2 gene of 11 days reprogrammed colonies of high and low TMRM 
samples. The difference off Sox2 fold induction was the greatest of all the pluripotent genes reaching in the low population 425 
times the levels expressed in CD34+. Fold induction was normalized with CD34+ population. *P<0,05 (P= 0,009662) 
Figures 26, 27 and 28 show the fold induction of Oct2 SOX2 and Nanog on the 
reprogrammed colonies of high and low populations. This value is correlated with the 
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amount of mRNA of each pluripotent gene and allowing to confirm if the 
reprogramming process successfully increased gene expression transcription. 
 
Figure 28– Graphic showing the fold induction of Nanog gene of 11 days reprogrammed colonies of high and low 
samples. In accordance with the previous graphics, the best results are shown in the low population. Fold induction was 
normalized with CD34+ population. *P<0,05 (P=6,95047E-06) 
The graphics on figure 26, 27 and 28 show greater increase in expression of the 
main pluripotent genes at mRNA transcript level in the low TMRM population when 
compared to the high TMRM population. 
It is important to note the big increase in terms of Nanog expression in the low 
TMRM population, especially because it was not one of the genes delivered by the 
lentiviral vector used in these experiments. This result clearly shows that the 
exogenous genes were able to activate the auto regulatory loop involving the 3 main 
pluripotent genes (Oct4, Sox2 and Nanog). 
Protein expression analysis by western blot confirmed the RT-PCR results 
showing higher Sox2 and Oct4 expression in the low TMRM population than in the high 
TMRM population. 
 
Figure 31 – Western blot images comparing Sox2 and Oct4 protein expression in reprogrammed colonies at 11 days. 
ECF reagent and a secondary antibody containing alkaline phosphatase were used in this western blot. 
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Figure 29 – Western blot results on Sox2 protein on reprogrammed colonies high and low with 11 days . These values 
are relative to the quantity of βactin protein that serves as housekeeping protein. It is clear the increase of Sox2 on the low 
population. 
 
Figure 30 – Western blot analysis  of Oct4 protein on reprogrammed colonies with 11 days for high and low 
populations. These values are relative to the quantity of βactin protein that serves as housekeeping protein.  Oct4 protein levels 
are also increased in the low population 
These evidences further support our previous results that claim that the 
population with low TMRM uptake is preferential for reprogramming.  
RT PCR of high and low TMRM population before reprogramming 
To complement our characterization of the high and low TMRM populations in 
terms of their stemness and metabolic profile we decided to evaluate the expression 
of glycolytic related genes such as Glut1, PFKM, HK2 and LDHA with RT PCR. Glut1, 
codes for a glucose transporter that allows glucose to cross the cell membrane through 
facilitated transport. The PFKM, is a phosphofructokinase isoenzyme that catalyses the 
phosphorylation of fructose-6-phosphate to fructose-1,6-biphosphate  during 
0
0,02
0,04
0,06
0,08
0,1
0,12
0,14
So
x2
/β
ac
ti
n
 p
ro
te
in
 q
u
an
ti
fi
ca
ti
o
n
Western Blot - Sox2
Low
High
0
0,001
0,002
0,003
0,004
0,005
0,006
0,007
0,008
O
ct
4
/β
ac
ti
n
 p
ro
te
in
 q
u
an
ti
fi
ca
ti
o
n
Western Blot - Oct4
Low
High
67 
 
glycolysis. Hexokinase 2 (HK 2), is another important glycolytic enzyme that 
phosphorylates glucose to glucose-6 phosphate being the first step in glycolysis. The 
LDHA protein is an enzyme used by high glycolytic cells to convert pyruvate and NAD+ 
on NADH and lactate in the final step of anaerobic glycolysis.  
The first important result of this experiment was the amount of mRNA 
extracted from each condition: 3,959 ng/µl in the low TMRM cells and 11,975 ng/µl in 
the high TMRM cells. This greater mRNA content in the high TMRM cells is an indicator 
of higher RNA polymerase II activity, which is characteristic of a more proliferative 
state. 
 
Figure 29 – Graphic showing fold induction of the glucose transporter Glut1. The high cells have higher expression of 
this gene than the low population. The error bars are standard error. 
 The results on figure 29, 30 and 32 point that the high TMRM population has 
glycolysis happening at higher levels than the Low TMRM cells. This can be concluded  
as more glucose should be transported inside the cell (figure 29), more piruvate should 
be converted on lactate at the end of glycolysis (figure 30) and higher levels of 
fructose-6-phosphate should be phosphorylated (figure 31). 
 
Figure 30 – Graphic showing fold induction of the anaerobic glycolysis related enzyme. There is also higher expression 
of this gene on the high population. The error bars are standard error. 
0
5
10
15
20
Fo
ld
 in
d
u
ct
io
n
 r
e
la
ti
ve
 t
o
 
C
D
3
4
+ 
ge
n
e
 e
xp
re
ss
io
n
Glut1 - RT PCR
low
high
0
20
40
60
80
100
120
Fo
ld
 in
d
u
ct
io
n
 r
e
la
ti
ve
 t
o
 
C
D
3
4
+ 
ge
n
e
 e
xp
re
ss
io
n
LDHA - RT PCR
Low
High
68 
 
 
Figure 31 – The mRNA levels of hexokinase 2 are higher in the low population. The error bars are standard error. 
 
Figure 32 – Results of RT PCR for PFKM showing higher expression on the high population but very similar with the 
result on the population. The error bars are standard error. 
We expected to see considerable differences in the expression of the glycolytic 
genes that pointed the low population as the one with the most glycolytic profile 
however interpretation of our data was not so direct. Our results show that the high 
population has more mRNA levels of glycolytic enzymes like LDHA and PFKM and the 
glucose transporter Glut1. These results apparently contradictory can make sense if we 
take into consideration the findings described in Pires das Neves et al (2010)106 and 
Romero-Moya et al (2012)92. Romero-Moya et al (2012), used a mitochondrial mass 
specific probe, the Mito tracker green, in human CD34+ cord blood cells to segregate 
two populations based on the uptake levels. They reported that the mitochondrial 
mass of the cells is correlated with mitochondrial membrane potential. Additionally, 
cells that had lower uptake of Mito tracker green were shown to be more primitive 
cells; while the cells with higher uptake were enriched in hematopoietic progenitors 
that have higher clonogenic capacity in vitro. Another important finding was that the 
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cells with higher Mito tracker green had higher levels of ATP and the levels in the low 
Mito tracker cells increased upon differentiation to similar levels of the high 
population. Moreover, the ATP levels in the high Mito tracker population remained 
constant during 15 days. 
Pires das Neves et al (2010), reported a positive correlation between available 
ATP levels and the rate of transcription in several mammalian cells. They also stated 
that cells with more mitochondrial mass had shorter cell cycle, which means higher 
proliferation rates. By crossing our data with this information, we conclude that our 
low population is more quiescent and for this reason has a lower metabolic demand. 
This was also supported by the inferior amount of mRNA content obtained for RT PCR 
analysis in the low TMRM population. This indicates less activity of RNA polymerase II. 
On the other hand as the high population has more hematopoietic progenitors 
with higher proliferation capacity they require more ATP and have higher glycolysis 
rate although they rely more on oxidative phosphorylation than the low TMRM 
population.  
An important remark that should be addressed in future experiments is the 
necessity of studying the expression of genes related with the mitochondrial 
respiratory chain. This way we could safely conclude that the higher glycolytic gene 
expression found in the high TMRM population was related with higher metabolic 
rates. Also one important experiment would be quantifying the levels of ATP in the 
high and low TMRM populations. 
 
Reprogramming in hypoxia 
CD34+ cells are mainly glycolytic and our results suggest that the low TMRM 
population showed better efficiencies of reprogramming because it was mainly 
constituted by the most primitive (CD133+CD34+) cells. With this in mind we thought 
that hypoxia, together with the reprogramming conditions used in the experiments 
reported above, could be a potent inductor of reprogramming.107 We were curious to 
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see if we would decrease or increase the gap between high and low TMRM cells in 
terms of efficiency of the process under hypoxia. 
Hypoxia leads to stimulation of Hypoxia Inducible Factor alpha, which is known 
to diminish the production of reactive oxygen species and avoid the depletion of 
important substrates used in the synthesis of biomolecules (such as citrate, an 
intermediate of Krebs cycle important for production of lipids).74, 108 These are 
important evidences that suggest that the reprogramming process may benefit from 
an hypoxic environment. The unlimited proliferation profile requires a high anabolic 
demand that can be sustained by discouraging the aerobic regeneration of the NAD+. 
109, 110Additionally by downregulation of the respiratory chain the cells will be less 
exposed to the damage of reactive oxygen species that is associated with senescence, 
DNA mutations and apoptosis111. On the other hand, stabilization of the HIF sub units 
should help to stimulate the glycolytic metabolism that is critical for pluripotency 
induction.84, 85 
Bone marrow Hematopoietic Stem Cells (HSCs) reside in a oxygen environment 
that ranges from <0,1%, for the most primitive HSCs, to 7% in perivascular areas, 
where the most committed precursors can be found112. Current literature support that 
0,1% oxygen levels support maintenance and return of HSCs to a quiescent state in 
G0;113 while 1% and 1,5% maintain cell proliferation, self renewal and preservation of 
HSCs in culture.107, 114 On the other hand, typical cultures of HSCs at 20% O2 lead to the 
exhaustion of the stem cell potential.112 
Next we describe the experiments of reprogramming under the influence of the 
hypoxic environment with only 0,5% oxygen. We anticipated that this concentration 
would allow a balance between the promotion of self-renewal and the maintenance of 
the primitive status. 
We evaluated how this new parameter can affect the efficiency of 
reprogramming in high and low TMRM populations. 
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Analysis of the percentage of cells infected with our viral vector 
On the following experiments we calculated the efficiency of the infection using 
FACS (Fluorescence-activated cell sorting) analysis of the cells one day after the last 
infection. We used FACSCalibur from Becton Dickinson and Cell Quest software.   
a b   
c  
Figure 33 a,b and c -  Evaluation of the fluorescence of CD34+ cells not infected used for negative control. a-Selection of 
the CD34+ viable cells in our sample based on SSC (Side Scatter -cellular complexity) and FSC (Forward Scatter - volume of the 
cells).b – Histogram where we definded the basal fluorescence of the cells that are not infected (M1) on FL2 channel and the 
fluorescence of infected cells (M2). c- histogram statistic .99% of the cells selected on the gate R1 were contained  on the M1 
interval. We considered that the cells that had fluorescence higher than this interval were infected with the vector. 
R1
M1
M2
His togram Statistic s
Marker Left, Right Events % Gated % Tota l Mean Geo Mean CV Median Peak Ch
All     1,  9910 452400 100.00 90.48 8.13 7.57 47.60 7.57 7
M1     1,    25 450675 99.62 90.14 8.01 7.52 37.04 7.50 7
M2    25,  9910 1773 0.39 0.35 39.85 36.44 60.70 32.78 25
Fi le: c el ls  only.001 Log Data Uni ts: L inear Values
Sample ID: cel ls only Patient ID: 
T ube: Panel: 
Acqu is ition Date: 27-Jul -12 Gate: G1
Gated Events: 452400 T otal  Events : 500000
X Parameter: FL2-H (Log)
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a  b  
c  
Figure 34 a, b and c – Analysis of the percentage of infected cells in the low TMRM uptake population 24 hours after 
infection. a – selection of the viable cell population. b histogram showing the number of cells that were contained in the interval 
M2 defined the fluorescence of the infected cells.. c –histogram statistics. We obtained 100% of the cells with fluorescence inside 
the interval M2. 
a b  
R3
M1
M2
His togram Statistic s
Marker Left, Right Events % Gated % Tota l Mean Geo Mean CV Median Peak Ch
All     1,  9910 88744 100.00 88.74 149.28 138.35 41.68 137.00 138
M1     1,    25 1 0.00 0.00 1.00 1.00 *** 1.00 1
M2    25 ,  9910 88743 100.00 88.74 149.28 138.36 41.67 137.00 138
Fi le: Data.041 Log Data  Uni ts: L inear Va lues
Sample ID: low Patient ID: 
T ube: Pane l: 
Acqu is ition Date: 17-Dec-12 Gate: G3
Gated Events: 88744 T otal  Events : 100000
X Parameter: FL2-H (Log)
R2
M1
M2
73 
 
c  
Figure 35 a, b and c - Analysis of the percentage of infected cells on the high TMRM uptake population 24 hours after 
infection. a – selection of the viable cell population. b – histogram showing the number of cells that were contained on the interval 
M2 defined the fluorescence of the infected cells. c – histogram statistic. As we obtained 99,98% of the cells with fluorescence 
inside the interval M2 we considered 100% of efficiency of infection within this condition 
 
Figure 36 – Overlay of the fluorescence of the three conditions. Cells only in grey. High  TMRM uptake cells in red and 
Low TMRM uptake cells in blue. 
Morphology of the reprogrammed colonies on hypoxia 
 On the 13th day of reprogramming we took pictures of the colonies on both 
conditions using a fluorescent microscope. 
a  b   
His togram Statistic s
Marker Left, Right Events % Gated % Tota l Mean Geo Mean CV Median Peak Ch
All     1,  9910 58840 100.00 78.61 133.63 122.02 58.50 118.64 106
M1     1,    25 12 0.02 0.02 17.52 14.45 38.81 18.60 24
M2    25,  9910 58828 99.98 78.59 133.65 122.07 58.48 118.64 106
Fi le: Data.040 Log Data Uni ts: L inear Va lues
Sample ID: high Patient ID: 
T ube: Panel: 
Acquis ition Date: 17-Dec-12 Gate: G2
Gated Events: 58840 T otal  Events : 74850
X Parameter: FL2-H (Log)
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c  
Figure 37 a) and b) Reprogrammed colony on the low TMRM uptake population condition in hypoxia. Although some 
heterogeneity could be seen on the morphology, the colony is very compact and shows high proliferation B)There is no 
fluorescence of the colony indicating successful reprogramming. c) Merge of the photo a and b.   
As shown in figures 37 and 38 both high and low TMRM conditions show similar 
response to this stimulus. The cells show high proliferative capacity and big sized 
colonies. 
a   b  
c  
Figure 38 a) and b)  Reprogrammed colony on the high TMRM uptake population condition in hypoxia. The aspect of 
the colony resembles the colony in the low TMRM condition. c) Merge of the photo a and b.   
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Figure 39 – Number of reprogrammed colonies in hypoxia for both populations. The number of colonies was 
very close in both populations. 
 
Figure 40 – Diameter of the reprogrammed colonies. There is no significant difference between the sizes of the colonies 
between high and low TMRM conditions. However, it is clear that there is an increase of proliferation in hypoxia when compared 
to the cells in normoxic condition. *P<0,05 (P=5,95832E-07 for the low TMRM uptake – normoxia vs hypoxia and P= 0,00107 for 
the high TMRM uptake cells – normoxia vs hypoxia) 
 
Figure 41 – Efficiency of reprogramming. These values were calculated considering the number of infected cells one day 
after the last infection.  
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We were expecting that the hypoxic environment could increase the gap in 
terms of efficiencies between the high and the low TMRM cells. Since the metabolism 
of the low TMRM cells does not rely on oxidative phosphorylation, this should be 
sufficient to allow a better adaptation to the new conditions.  
Interestingly, however, we observed that both populations showed similar 
reprogramming results at low oxygen concentrations. With these atmospheric 
conditions the high population seems to be forced to shift to the glycolytic metabolism 
that characterizes the low population, allowing an improvement in reprogramming 
efficiency. On the other hand as the low population does not require oxygen there are 
no stimuli affecting the metabolism and thus there will be no significant change of 
efficiency. This increase in proliferation status was consistent with the report on 
Forristal et al 2010 where colonies where HIF2A and HIF3A expression had been 
disrupted experimented a reduction in colony size.91   
As for the low efficiencies obtained (figure 41), these are to be expected as the 
cells were cultured in matrigel (from BD Biosciences) with conditioned medium instead 
of using MEFs as feeder cells.115 The feeder cells provide appropriate cell contacts, 
various growth factors and extracellular matrix (ECM) proteins that are required for 
the undifferentiated growth of hPSCs.116 
 
 
Feeder-free reprogramming in Normoxia vs Hypoxia 
  
To fully prove the negative effect of culturing our iPSCs using matrigel and 
conditioned medium instead of a feeder cell culture we decided to repeat the hypoxic 
reprogramming and compare it with the efficiencies in normoxia under the same 
conditions. Additionally, we also reprogrammed high and low cells in normoxia using 
MEFs.  
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a  b            
c  
Figure 42– a) -Low TMRM cells cultivated on matrigel with conditioned medium in normoxia 15 days after last infection. 
b ) Cells on the fluorescent channel. This condition failed to generate colonies. c) Merge of the photo a and b.   
As shown in figure 42 and 43 the cells cultured in normoxia with the same 
feeder free system failed to generate reprogrammed colonies. The low TMRM 
condition did not show any colony while the high TMRM cells formed a small colony 
but did not have embryonic features and still expressed the fluorescent reporter. 
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a  b           
c  
Figure 43 – a ) High TMRM cells cultivated on matrigel with conditioned medium 15 days after last infection. b) These 
cells also failed to achieve the pluripotency state as the colonies formed still expressed d’Tomato protein, did not have round 
shape, without a well defined border, not compact and showed signs to be disintegrating. c) Merge of the photo a and b.   
 
On the other hand we confirmed the good morphology of the colonies cultured 
in hypoxia and feeder free conditions. 
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a b  
c d  
e f  
Figure 44 a),b),c),d)- Reprogrammed colony of the low TMRM condition cultured in hypoxia on matrigel with 
conditioned medium 15 days after last infection. As it is illustrated there was the requirement to take more than one picture to 
evaluate a single colony. Although the morphology of the colonies was sacrificed there was a clear improvement of proliferation of 
the cells. e and f) Merge of the photo a, b c and d.   
In the hypoxia condition we confirmed the expected results both in high and 
low TMRM uptake cells (figure 44 and 45): big colonies, very compact and with cells 
with high nucleus/cytoplasm ratio when compared with previous data (figure 33 and 
34). 
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a  b  
c  
Figure 45 a) and b) Reprogrammed colony of the high TMRM condition cultured in hypoxia on matrigel with 
conditioned medium 15 days after last infection. The results are similar when compared to the low population on the same 
conditions although the colonies were smaller. c) Merge of the photo a and b.   
 
Figure 46 – The number of reprogrammed colonies was practically the same on hypoxic conditions, reinforcing the 
effect of hypoxia in equalizing efficiency between low and high TMRM populations. In normoxia the low and high TMRM uptake 
conditions failed to generate any reprogrammed colony.  
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Figure 47 – The size of the colonies was also similar since the difference is contained in the error bar calculated 
(standard error). The error bar is the standard error. 
 
 
Figure 48 – The reprogramming efficiency was very close in hypoxia on both populations. There was however a 
reduction if we compare the results with the ones obtained on the previous study (figure 35). 
There was a decrease in the efficiency (figure 48) when compared to the results 
obtained in our previous experiment in hypoxia (figure 35). We determined the 
efficiency as the number of colonies generated per infected cell. As these colonies 
have the tendency to grow to large sizes it could be that some of the colonies may be 
the result of aggregation of several smaller colonies. This would mask the real number 
of colonies and result in a false reduction of efficiency.  
 
Nonetheless these results were very important to elucidate the impact of the 
hypoxia in boosting efficiency. Not only this stimulus allowed generation of 
reprogrammed colonies in both conditions, which was not possible in normoxia, but 
also allowed similar efficiencies in both populations. 
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Fine-tuning data analysis 
 Has it was mentioned above we had two problems in our previous experiment: 
the first was the possible excessive error that we introduced with the estimation of the 
number of colonies per area; the second was the introduction of a step of passaging of 
the cells during the reprogramming process. In order to overcome these problems we 
have started with a smaller cell density (10000 per well of a 6-well plate) and counted 
all the colonies present in each well. Additionally, we tried to reduce the stress 
imposed to the cells by passaging. 
a  b  
c  
Figure 49 a) andb) Reprogrammed colony of the low TMRM condition in normoxia cultured on MEF’s 15 days after last 
infection. a) the aspect of the colony was improved when compared with the results obtained on the first experiment as the 
colonies stayed in culture additional time. c) Merge of the photo a and b.   
 
 
Comparing the results of this experiment (figure 49 and 50) with our first data 
in normoxia (figure 21 and 22) it is clear that the colonies that were not passed 
showed in both conditions better morphology, with greater size, round shape and well 
defined borders. Furthermore, the cells of the high TMRM population did not show 
signs of disintegration. This suggests that the stress imposed during the passages is 
deleterious for the reprogramming process. 
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a  b  
c  
Figure 50 a) and b) Reprogrammed colony of the high condition in normoxia cultured on MEFs 15 days after last 
infection. c) Merge of the photo a and b.   
 
 
Figure 51 – Number of reprogrammed colonies in normoxia. It is possible to confirm the greater number 
of colonies in the low population. The error bar is the standard error. 
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Figure 52 – The diameter of the reprogrammed colonies is considerably greater in the low population, showing greater 
proliferation capacity. The error bar is the standard error. 
 
Figure 53- Although the difference on the reprogramming efficiency is smaller than the number previously estimated, 
there is still a clear gap between the two samples. The low population is better suited to generate more colonies. 
Comparing these results obtained in normoxia (figure 53) with our previous 
data (Figure 18) we can see a significant reduction in the global efficiency and the gap 
between the 2 populations is also decreased.  
 
Effect of antimycin A on hypoxic reprogramming  
The results obtained in hypoxia were quite promising however we did not have 
the required equipment to conduct an experiment where cells are kept at low oxygen 
concentrations even while changing culture media. During this procedure it seems that 
there is a reoxygenation burst in the cell environment and this may induce deleterious 
effects in terms of cell fate and state.117 For this reason we decided to introduce a 
complex III inhibitor of the respiratory chain of mitochondria. This should reduce the 
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oxygen impact during medium change, which could compromise the induction of 
pluripotency. 
To test this new variable we repeated our study in hypoxia with and without 
antimycin A for both populations.  
a  b            
c  
Figure 54 –a) and b) Low cells cultivated on matrigel with conditioned medium 15 days after last infection without 
antimycin A treatment.. These results were consistent with the data obtained on previous experiments as the morphology show 
some heterogeneity but with high proliferation capacity. c) Merge of the photo a and b.    
The cells that were not exposed to antimycin A treatment (figure 54 and 55) 
showed a morphology consistent with previous results in hypoxic conditions (figures 
37, 38, 44 and 45). The colonies were big, compact and they didn’t express the 
fluorescent reporter. 
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a  b             
c  
Figure 55 a) and b) High cells cultivated on matrigel with conditioned medium 15 days after last infection without 
antimycin A treatment.. These results resemble the low population on the same conditions . c) Merge of the photo a and b.   
a  b            
c  
Figure 56a) and b) – Low cells cultivated on matrigel with conditioned medium 15 days after last infection with 
antimycin A treatment. The colonies do not show significant differences from the condition without antimycin A treatment. c) 
Merge of the photo a and b.   
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Antimycin A treatment did not reveal a visible impact in the morphology of the 
colonies as we can see in figures 54, 55, 56 and 57. 
 
a  b           
c  
Figure 57 a) and b) High cells cultivated on matrigel with conditioned medium 15 days after last infection 
with antimycin A treatment. The colonies do not show significant differences from the condition without antimycin A 
treatment. c) Merge of the photo a and b.   
In this study it was not possible to monitor the number of colonies during the 
experiment since we wanted to protect cells from the stress of reoxygenation that 
could lead to differentiation and compromise the experiment. Another issue that 
compromised this analysis was the big size of the colonies that raised obstacles in the 
identification of the borders between the colonies. 
There was a high proliferation rate in the colonies. As the colonies grew they 
started to coalesce making it impossible to evaluate their accurate number. Taking this 
into account we decided to determine the area occupied by reprogrammed cells. We 
analysed a photo from each condition cultured in a 6 well plate and estimated the area 
using imageJ software. 
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Figure 58 –Area of reprogrammed cells in cm2 in a 6 well plate in the 4 conditions in hypoxia: high with and without 
antimycin A treatment and low with and without antimycin A treatment. 
With the introduction of the antimycin A in the culture conditions we could see 
that the differences between high and low TMRM populations were attenuated. This 
was visible both in terms of reprogramming efficiency and proliferation and by analysis 
of gene expression by RT-PCR of the 3 main pluripotent genes (Oct4, Sox2 and Nanog).  
 
Figure 59 – Oct4 expression for all the hypoxic conditions (with and without antimycin A treatment). LowH -  Low cells 
on hypoxia. HighH – high cells on hypoxia. LowHA – low cells in hypoxia with antimycin A treatment. HighHA – High cells in hypoxia 
with antimycin A treatment. The results were normalized for CD34+ cells expression. The higher epression is shown on low 
population without antimycin treatment. The antimycin A improve the fold induction of the pluripotent gene on the high 
population (which depended more on oxidative phosphorylation). The fold induction on the low population was decreased. 
*P<0,05 (P=0,000269 for Antimycin A non treated cells; P=0,574554  in Antimycin A treated cells). The difference is only 
statistically significant on the cells that did not had the inhibitor. 
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Figure 60 – Sox2 expression for all the hypoxic conditions (with and without antimycin A treatment).  LowH - Low cells 
on hypoxia. HighH – high cells on hypoxia. LowHA – low cells in hypoxia with antimycin A treatment. HighHA – High cells in hypoxia 
with antimycin A treatment. The results were normalized for CD34+ cells expression. The results for the fold induction of this gene 
were consistent with the Oct4 results. The higher fold induction was seen in the low population without antimycin A treatment. 
The use of the inhibitor made both population to have a similar behaviour on the expression of the pluripotent gene. The error bar 
is the standard error. *P<0,05 (P= 0,00216 for Antimycin A non treated cells; P=0,384989 in Antimycin A treated cells). The 
difference is only statistically significant on the cells that did not have contact with the inhibitor. 
 
Figure 61– Sox2 expression for all the hypoxic conditions (with and without antimycin A treatment).  LowH - Low cells 
on hypoxia. HighH – high cells on hypoxia. LowHA – low cells in hypoxia with antimycin A treatment. HighHA – High cells in hypoxia 
with antimycin A treatment. The results were normalized for CD34+ cells expression. The low population expressed more quantity 
of Nanog mRNA than the high population without antimycin A treatment. However the inhibitor improved fold induction of this 
gene and equalizing the result on both conditions. The error bar is the standard error. *P<0,05 (P=0,037867101  for Antimycin A 
non treated cells; P=0,35843945 in Antimycin A treated cells). The difference is only statistically significant on the cells that did not 
have contact with the inhibitor. 
Although the efficiency of reprogramming could not be improved in the low 
TMRM population by using this inhibitor there was a positive effect in making both 
populations to have a similar behaviour and with a reasonable expression of the 
pluripotent genes. The fact that there was a drop in expression of Sox2 and Oct4 
(figure 59 and 60) in the Low TMRM population with antimycin treatment did not have 
parallel in the expression of Nanog (figure 61) or in the proliferation (figure 58) of the 
reprogrammed cells. We are not aware of the reason for this effect. Future 
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experiments should focus on this effect to try to validate the use of antimycin to 
generate iPSCs under hypoxia conditioning where a full hypoxic system is not available 
in the laboratory. 
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Conclusion 
As reprogramming consists in a stochastic process, a good way to increase 
efficiency is lowering the number of events required to achieve pluripotency by 
selecting the less differentiated population.  
Our work successfully developed a new method to select the cells within the 
cord blood CD34+ population with more potential for pluripotency induction. We 
managed to correlate the mitochondrial phenotype with the maturation of the cells by 
analysing the membrane potential with TMRM. The results clearly point the cells with 
low mitochondrial membrane potential as the best candidates to achieve pluripotency. 
The cells with high mitochondrial membrane potential showed practically half of the 
reprogramming efficiency. Additionally surface marker characterization confirmed a 
more naïf stage with less expression of lineage commitment markers for the low 
TMRM population. The colonies of the low population that no longer expressed the 
genes delivered by the viral vector had higher expression of the pluripotent genes 
Nanog, Oct4 and Sox2; confirmed by mRNA analysis using RT-PCR. Also, western Blot 
analysis of Sox2 and Oct4 protein was consistent with RT-PCR data. 
On the other hand, the culturing conditions were shown to have an important 
impact in the efficiency of pluripotency induction. The hypoxic environment improved 
proliferation in both conditions and allowed to obtain reprogrammed cells without 
requiring the use of feeder cells with similar efficiencies. 
Furthermore the use of antimycin A has proven to be a mean to homogenize 
the behaviour within the CD34+ cell population. This mitochondrial complex III 
inhibitor improved the efficiency of reprogramming in the high TMRM population, 
which was confirmed with RT PCR gene expression.  
While the traditional method to isolate an immature population within the cord 
blood is very complex, time and resource consuming, requiring the use of several 
antibodies, our method offers a new cheap alternative to perform isolation.  
As the reprogramming process demands a delicate balance between several 
variables, where time is a very critical factor, our method reduces sorting time several 
fold and this seems to be crucial to increase efficiency. By selecting the cells according 
with the mitochondrial phenotype instead of marker expression we optimized this step 
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reducing the amount of stress imposed to the cells. We believe this may diminish cell 
death and differentiation. 
Other important aspect is related with the complexity of the method. The use 
of antibodies that label surface markers requires the coordination of the wavelength 
emission of the channels and the use of several control samples to reduce the 
interference of the different markers. This interference leads to additional time 
required to distinguish false positives, higher number of ambiguous events discarded 
and the requirement of a highly skilled technician to collect the cells and interpret the 
data. Also, reducing the number of antibodies for sorting is also important for cost 
reduction of the overall process and incubation time of the samples. 
We hope our work may contribute to increase the efficiency of other 
reprogramming studies. We also expect to introduce a new methodology of research 
for the segregation of primitive cells of the umbilical cord blood as we show quite 
promising results in our selected population.  
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